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Foreword 
Tsetse-transmitted trypanosomosis continues to be a major constraint to livestock productivity in 
sub-Saharan Africa. The four important livestock trypanosomes, Trypanosoma congolense, T. 
vivax, T. brucei and T. evansi, cause high mortality in the acute phase and severe production 
losses in the chronic phase of the infection. The control of the disease is still principally based 
on vector management and the use of a limited number of trypanocidal drugs available in the 
market. Alternative control measures involve the use of trypanotolerant breeds of cattle, 
particularly in West Africa where trypanosomosis is a constant threat. No new drugs, vaccines 
or alternative control measures have been developed and are unlikely to be forthcoming in the 
near future. 
Accurate diagnosis of trypanosomosis is an important component of the disease control and still 
remains a challenge due to very low parasitaemias in the majority of infections. In an attempt to 
improve detection of trypanosomes in subclinical and chronic infections, antigen detection 
ELISAs (Ag-ELISAs), based on species-specific monoclonal antibodies were developed in 1989 
by the International Laboratory for Research on Animal Diseases (ILRAD). After the successful 
validation exercise in the laboratories in Kenya, the assays were distributed to 13 laboratories in 
sub-Saharan Africa through the joint FAO/IAEA Division, Vienna, for field validation and wider 
evaluation. Following this exercise, it was found necessary to modify the procedure for the Ag-
ELISA. This was done by joint division of FAO/IAEA and subsequently distributed through the 
FAO/IAEA Co-ordinated Research Programme to a number of African countries for routine use 
in the control of trypanosomosis. 
A number of workshops has been held to discuss the performance of the Ag-ELISA; the most 
recent of these was organised by FAO/IAEA in 1995 and held at ILRI's campus in Addis Ababa, 
Ethiopia. The most important conclusions and recommendations made at this workshop were 
that the Ag-ELISAs have a high specificity of between 95 and 99%, and were valuable for 
detection of chronic and mixed infections. However the assays exhibited poor sensitivity 
necessitating concurrent use of a parasitological test such as the buffy coat technique (BCT) in 
field surveys. 
Since this workshop, and through continuing collaboration with FAO/IAEA and the partners in 
the national laboratories in Africa, it has become clear that the modified version of Ag-ELISAs 
shows poor sensitivity in the field and their performance appears to vary significantly between 
laboratories. As part of continuing development and evaluation of these tests, ILRI organised a 
workshop to assess the current status of Ag-ELISAs and identify ways of improving them. The 
workshop entitled 'Evaluation of the Performance of Antigen-ELISAs for the Detection of 
Trypanosomes' was held at ILRI between 9 and 11 December, 1996 with the following main 
objectives: 
 to define the circumstances of use and requirements of trypanosome antigen detection 
assays; 
 to develop quantitative standards on which their performance can be assessed; 
 to examine the problems of trypanosome antigen-ELISAs and devise ways and means 
of circumventing them; and 
 to recommend protocols for the development, standardisation and validation of future 
antigen detection assays for trypanosomes. 
In order to seek advice from a wide range of disciplines in the workshop, a number of scientists 
from eight countries representing epidemiologists, field workers, laboratory technologists, 
serologists and test developers were invited. The workshop was held over a period of three 
days. The first day was devoted to presentations of key papers covering the epidemiology of 
trypanosomosis and the requirements for diagnostics, the performance of Ag-ELISAs in various 
laboratories, technical aspects of Ag-ELISAs and the use and value of alternative tests. The 
remaining two days were devoted to addressing two specific issues: a) shortcomings of Ag-
ELISAs and possible solutions; and b) diagnostic needs for trypanosomosis and quantitative 
standards. 
This publication contains all the formal presentations, summaries of discussions and a set of 
recommendations made at the workshop. These will be extremely valuable for both ILRI and the 
joint division of FAO/IAEA in defining research agenda for improvement of the Ag-ELISAs and 
development of new diagnostics for detection of trypanosomes. 
The organising committee would like to thank a number of ILRI scientists who assisted in 
formulating the programme for the workshop, the rapporteurs for their timely submissions of the 
summaries of the discussion after formal presentations, and the invited participants for keeping 
the discussion open, honest and interactive. We thank Dr John McDermott for assisting in 
summarising the group discussions. We are also grateful to Dr Rob Eley for his help and 
assistance in organising the conference and Mr Peter Werehire for proofreading the text and 
typesetting the book. 
This workshop was in part financed by the Government of Belgium. 
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Rachael Masake 
John Rowlands 
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Diagnostic tests requirements, development, standardisation 
and validation 
Requirements for diagnostic tests to improve field 
investigations into the epidemiology and control of 
trypanosomosis 
J. McDermott Department of Population Medicine, University of Guelph, Guelph, N1G2W1, 
Canada 
Summary 
There are multiple requirements for diagnostic tests in the study of epidemiology and control of 
trypanosomosis. These tests need not be perfect; what is crucial is that they provide results that 
are sufficient for the purposes demanded. In this paper different circumstances are outlined for 
which tests are needed for epidemiological investigations of trypanosomosis; the requirements 
for diagnostic tests are described for each of these circumstances. The focus, as in this 
workshop, is on diagnostic tests for livestock rather than for tsetse populations. The 
requirements for the performance of trypanosomosis diagnostic tests in terms of their sensitivity 
and specificity to estimate the seroprevalence, disease incidence and other epidemiological 
parameters can vary widely when these tests are required to answer different objectives. 
Increased sensitivity and specificity will be needed for the estimation of parameters for smaller, 
specifically defined population groups. 
Epidemiology of trypanosomosis, basic patterns influencing control 
programmes 
A key feature of the epidemiology of trypanosomosis in Africa is the variability of both its 
distribution and importance between different ecological areas and farming systems. As with 
other vector-borne diseases, tsetse distribution and density are most influenced by spatial 
factors such as climate, vegetation and land utilisation. Given these spatial differences, it is 
important to be able to characterise areas so that trypanosomosis control programmes can be 
targeted to areas in which maximum benefits will be achieved. Three important criteria for 
characterising areas as to their relative suitability for control programmes are: 1) epidemiologic 
disease status (endemic stability; prevalence or incidence of infection and disease), 2) 
economic costs (morbidity, mortality and other production effects) and 3) cost and efficacy of 
measures to control trypanosomosis. Given the variability of incidence of trypanosomosis from 
area to area, usually a large number of areas, with relatively few farms and animals, need to be 
sampled to obtain confidence intervals of prevalence or incidence estimates which are 
sufficiently narrow to detect area-to-area differences. 
Superimposed on this basic spatial pattern are temporal changes (seasonal or longer-term 
trends) and differences among animals (e.g. species, breed, age), so that the occurrence and 
impact of trypanosomosis depends on tsetse challenge and on a number of other factors such 
as host distribution, livestock breeds, farming practices and trypanosomosis control practices. 
Defining the size and boundaries of target areas of interest for both epidemiological studies and 
control programmes can be difficult. Trypanosomosis risk can vary both by larger agro-
ecological areas which would correspond in many cases to administrative units for control 
planning purposes or by much smaller areas which exhibit local variations in vegetation within a 
grazing area (Wacher et al 1994). In this paper, the areas referred to are administrative areas 
for disease control purposes. Since control programmes are usually targeted at areas (or if 
targeted at herds and animals it is usually within high risk areas), it is sensible to try and classify 
areas epidemiologically, taking into account major risk factors. For tick-borne diseases, this has 
been done by classifying areas as to their endemic stability (Norval et al 1992; Perry and Young 
1995). 
Endemic stability has not been a concept commonly applied to studies of the epidemiology of 
trypanosomosis but it could be a useful paradigm for helping to consider the important 
interrelationships of factors influencing trypanosomosis occurrence and impact. Endemic 
stability is a relative term, describing the stability of the relationships between host(s), agent, 
vector, farming system, chemotherapy regime and environment. Where endemic stability exists 
there is a balance between host factors, pathogen factors and disease challenge. Endemic 
diseases occur at predictable rates in an area, whereas epidemic diseases occur much in 
excess of predictions. Combining the concepts of endemicity and stability is useful in planning 
control programmes, particularly in circumstances where sustained eradication is not feasible. 
Thus, for the given environmental circumstances, different combinations of control measures 
(e.g. introduction of trypanotolerant breeds, changes in grazing practice, strategic tsetse control 
and chemotherapy) can be tried in order to move towards an endemically stable state with low 
disease incidence. The principal challenge of this strategy is to minimise disease losses in a 
cost-beneficial fashion while the desired endemically stable trypanosomosis disease control 
state is being established. Figure 1 depicts common relationships between seroprevalence, 
disease prevalence, endemic stability and risk factors for many vector-borne diseases. As can 
be seen on the right hand Y-axis of Figure 1, for simple classifications into either 1) very low 
challenge, 2) endemically unstable and 3) moderate to high challenge endemic stable 
categories, only modest diagnostic test performance is required. 
Generally, in endemically stable areas, trypanosomosis risk for most animals will be relatively 
constant. However, in endemically unstable areas, trypanosomosis risk will be more 
heterogeneous and can vary by animal (e.g. breed, age), farm (e.g. grazing system, control 
measures) and micro-area (e.g. forests, riverbanks). In these areas, diagnoses by animal and 
farm are often demanded. 
Studies to investigate the epidemiology and improve the control of 
trypanosomosis 
To comment on the needs and requirements for diagnostic tests, it is first necessary to 
summarise the types of studies needed to investigate the epidemiology and improve the control 
of trypanosomosis. These are somewhat arbitrarily categorised into four main groups based on 
objectives: 1) studies to characterise the status of areas, 2) studies to assess changes in status 
over time, 3) controlled trials for testing different treatment or clinical decisions, and 4) studies to 
estimate parameters for modelling. These categories are not mutually exclusive. Within each 
category, the information that might be obtained and the relative test performance needed to 
achieve it with the required precision can then be considered. These are summarised in Table 
1. 
 Figure 1. Hypothesised relationships between seroprevalence, morbidity and mortality rates 
and factors associated with different epidemiological states used for a number of vector-borne 
diseases (modified from Perry and Young 1995). 
Studies to characterise target areas for control 
For cross-sectional or longitudinal studies to characterise endemic stability and to estimate the 
relative incidence or prevalence of trypanosomal infection and morbidity in different areas, 
relatively low sensitivity (Se = 0.2–0.5) is acceptable (Table 1; Figure 1) as long as: 1) the 
combination of test sensitivity and specificity are noticeably better than occurrence by chance 
(i.e. the test predicts better than tossing a coin), 2) test sensitivity and specificity are consistent 
across areas, farms and animals and 3) trypanosomosis is not rare. If test errors are random, 
deficiencies in test performance can be compensated for by increasing sample size. 
Unfortunately, an assumption that the sensitivity and specificity of some tests (antigen- and 
perhaps antibody-detection ELISA tests) are homogenous across areas (beyond within-
laboratory repeatability and between-laboratory differences) may not always be correct and 
needs to be evaluated. 
Table 1. Studies to investigate the epidemiology and improve the control of trypanosomosis: 
objectives, study design, information that might be obtained and relative test performance. 
Study objectives Study design 
Information that might be 
obtained 
Relative 
test† performance 
Characterise target areas for 
control 
Observational: 
cross-section or 
longitudinal 
1. Presence of infection Low–moderate‡ 
2. Identification of parasite 
3. Morbidity/ mortality rate 
4. Effects on production 
5. Potential control benefits 
Estimate changes in 
occurrence or impact over 
time to assess effects of 
control programme 
Observational: longitudinal 
Observational: 
longitudinal 
1. Presence of infection  Moderate–high§ 
2. Identification of parasite 
3. Morbidity/mortality rate 
4. Effects on production 
Test different treatment or 
clinical decisions for use in 
control programmes 
Experimental: clinical field 
trials 
Experimental: 
clinical field trials 
1. Presence of infection Moderate–high§ 
2. Identification of parasite 
3. Morbidity/mortality rate 
4. Effects on production 
5. Other specialised 
measures¶ 
Estimate parameters for 
disease models 
Observational: 
longitudinal 
Experimental: 
field and 
laboratory 
1. Presence of infection Moderate–high§ 
2. Identification of parasite 
3. Morbidity/mortality rate 
4. Immune responses 
5. Other specialised 
measures¶ 
†For tests with a dichotomous outcome; approximate sensitivity (Se) and specificity (Sp) values for relative 
performances presented are: low (Se: 0.2–0.4; Sp: 0.4–0.7), moderate (Se: 0.4–0.8; Sp: 0.7–0.9) and 
high (Se: >0.8; Sp>0.9); see Martin et al (1987) for additional discussion on sensitivity and specificity.  
‡Low–moderate for sensitivity, parasite identification by skilled personnel should have a specificity of 1. 
§Interpretation of infections in individual animals requires higher performance overall than in herds or 
areas and is a function of the relative costs of false positives and false negatives.  
¶e.g. host genetic markers, level of infection, measures of host response for trypanotolerance; in some 
areas and cases species or other identification may be important to assess transmission. 
The performance requirements for serological or other tests to link infection to morbidity and 
mortality events and (subclinical) production losses will require at least a moderate (Se: 0.4–0.8; 
Sp: 0.7–0.9) level of performance since the number of animals used to estimate these 
parameters will usually be limited (Table 1). The performance of microhaematocrit (Woo 1971) 
or buffy coat techniques (Murray et al 1977), by comparison, has lower sensitivity (<0.4 in many 
circumstances) and high specificity (essentially 1 with experienced personnel). When sample 
sizes are small, using either of these as the diagnostic test may restrict the ability to find 
significant associations with production losses, although, the low sensitivity can be improved 
with repeated sampling. In addition, there has been interest in assessing whether there are any 
production effects of chronic infections in livestock having levels of parasites below the 
threshold detected by buffy coat examination. This would require that tests designed to assess 
infection status, such as the antigen-detection ELISA (Nantulya and Lindqvist 1989), be used 
semi-quantitatively rather than just qualitatively to estimate what levels of infection might 
interfere with production. Again, moderate levels of performance may suffice for mean effect 
estimates in an area or over a number of areas. However, if the test is to be used for individual 
animal diagnosis and treatment decisions, high (Se: >0.8; Sp >0.9) performance might be 
required depending on the incidence of trypanosomosis and the costs of correct and incorrect 
treatment decisions (Table 1). 
Observational studies of changes in occurrence or impact over time to 
assess effects of control programmes 
Relative test performance requirements for tests used to estimate changes in trypanosomosis 
occurrence or impact over time will also depend on the size of the differences in infection, 
morbidity, mortality rates and other production losses to be compared. Requirements will be 
higher than for characterising areas and will increase in proportion to how small a difference 
needs to be detected (Table 1). Increasingly, estimates of the impact of control programmes are 
required more quickly, so that small differences over short time periods will be used to predict 
likely trends and revise programmes in progress. However, such assessments of changing 
incidence or prevalence over time are subject to problems of confounding with other factors that 
change over time (Rowlands 1994; Rowlands et al 1996), thus, requiring similar trends to be 
observed over multiple time periods and/or sites to give us sufficient confidence that any effects 
observed are important. 
Clinical trials to assess control and treatment programmes 
Clinical field trials are, by design, more powerful in estimating differences between groups to be 
contrasted because other factors which can confound the contrast of interest are on average 
balanced by random allocation. However, depending on the study costs per experimental unit, 
there may be severe restrictions on the potential sample size. Test errors will, of course, 
increase the required sample size. 
For both observational and experimental studies, the unit of observation or randomisation may 
be area, farm, animal or combinations of these. As described above, specific decisions at the 
animal level relying on diagnostic tests will be completely susceptible to individual test errors 
while for herd- or area-level decision-making individual test errors are averaged together with 
correct test results. If mistakes in individual animal treatment decisions are costly, high test 
performance will be required (Table 1). In the past, field trials for comparing control options 
between trypanosomosis control areas have rarely been conducted. The major difficulty is that a 
number of control areas need to be included. One possible strategy would be to subdivide the 
target area for a national or regional trypanosomosis control programme into a number of 
smaller control areas and begin control options to be compared in a randomly selected subset 
of these. This would allow for both the assessment and delivery of the control programme to be 
integrated. 
Studies to estimate parameters for disease models 
For longitudinal studies or clinical trials to estimate parameters for modelling the transmission 
dynamics of trypanosomosis, the data are divided more and more finely to classify animals into 
different epidemiologic states. Basic states include: susceptible, latent, infectious and immune 
(Anderson and May 1991). However, these may need to be subdivided by age or breed to 
account for potentially important variations in transmission. The more that data from studies to 
estimate these parameters need to be subdivided, the higher are the levels of test performance 
required (Table 1). Relative to some other livestock and human diseases, transmission models 
for trypanosomosis are undeveloped. This is likely a function of both the complexity of modelling 
trypanosomal infections (indirectly transmitted microparasites) and the only recent interest in 
integrated methods to control trypanosomosis. 
For transmission models, the population and infection dynamics of both the tsetse and animal 
populations are important. In the animal population, not only the presence of infection, but also 
relative levels of infectiousness and immunity may need to be assessed. Thus, no one test will 
be sufficient. Because of the crucial importance of temporal as well as spatial patterns of animal 
infections in assessing transmission dynamics, antigen-detection methods such as the ELISA 
have a potentially important role to play. However, because of the detail of information required, 
the standards of test performance demanded to meet these objectives are high (Table 1). 
Diagnostic tests—needs and priorities 
For all categories of studies listed in Table 1, direct microscopic identification of parasites and/or 
other methods to detect the presence of infection in animals are important in estimating both the 
effects of infection on production (e.g. morbidity, mortality, weight loss) and transmission 
dynamics. Less commonly required is the detection of immune response to previous infection. 
In practice, available antibody detection assays (e.g. Luckins et al 1978) are used primarily as a 
surrogate measure of previous infection status rather than a measure of the effectiveness of the 
immune response (its use for this latter objective needs to be evaluated). 
In the field, direct microscopic examination of the buffy coat of spun microhaematocrit tubes 
(Woo 1970, 1971) or its refinements (Murray et al 1977) are standard and robust techniques 
which can and have been used effectively to characterise areas (Nankodaba et al 1988), assess 
control success (Leak et al 1995) and diagnose trypanosomal infections in individual animals for 
subsequent animal or herd treatment. Their high specificity (1 by experienced persons) is a 
major advantage relative to antibody and antigen detection systems. However, if detection of 
low levels of parasitaemia is either important or required, then the sensitivity of the buffy coat 
technique is relatively low compared to what might be achieved by other techniques. As with 
other tests with a specificity of 1, it is possible to increase the sensitivity by examining multiple 
tubes (Woo (1970) recommends three) or multiple samples over time. The threshold level of 
parasitaemia which results on average in significant production effects needs further 
elaboration. It has been hypothesised that parasitaemia levels below what can be detected by 
buffy coat examination may cause production losses (Trail et al 1992a, 1992b) but this has yet 
to be fully demonstrated. The other advantage of buffy coat examination is that it simultaneously 
provides an estimate of reductions in PCV, which have also been shown to be associated with 
production loss (Rowlands et al 1995; Trail et al 1991). 
As described above, characterising or comparing areas is a very important component of the 
epidemiological assessment of trypanosomosis control. In comparing areas, it is crucial that test 
performance is consistent from area to area. This may be more difficult to achieve for indirect 
methods such as antigen- or antibody-detection ELISAs, for which variations in trypanosomal 
populations might cause variations in test performance. Thus, the assessment of these methods 
prior to their widespread distribution in the field needs to consider test consistency in a wide 
variety of circumstances. 
Some of the tests in current use were developed to distinguish infections of different species of 
trypanosomes. Differentiating between infections of trypanosomes which are potentially 
'pathogenic'(Trypanosoma brucei, T. congolense and T. vivax) has been considered useful in 
some situations. Trail et al (1992b) in data from a ranch in Gabon, found production differences 
for animals detected by Ag-ELISA to be infected by T. congolense, but no differences were 
detected between animals positive and negative for any trypanosome, ignoring species. It is 
difficult to know how much emphasis should be placed on species differentiation for routine 
screening tests. Species differentiation will be important in the research domain and perhaps its 
importance should be well justified there first, before greater efforts are made to develop 
species-specific screening tests for widespread use. 
There are a number of other diagnostic testing needs with potential widespread application 
which also require further refinement in the research domain. Two of particular importance are 
diagnostic methods for assessing trypanotolerance of animal populations (Trail et al 1992a, 
1994), e.g. level of trypanosomal infection (for associations with production effects), measures 
of host immune response and host genetic markers, and methods for determining drug 
sensitivity of trypanosomal populations (e.g. assays to detect circulating drug levels). In the 
research domain, a broad range of potential diagnostic methods should be considered and 
critically compared (including immunological and nucleic acid methods) by skilled technical staff 
using samples from both controlled laboratory and field situations. The assessment and 
interpretation of the results would be best debated among a wide range of researchers 
(molecular biologists, immunologists, epidemiologists) and field users before widespread 
distribution of these tests is considered. 
What are the priority needs for improving the use and interpretation of diagnostic tests for field 
investigations of the epidemiology and control of trypanosomosis? A key requirement is to link 
the use and interpretation of tests to specific diagnostic objectives. There are three main priority 
areas for improving the routine diagnostic tests for trypanosomosis discussed in the paper. The 
first is that the epidemiological states to be diagnosed must be clearly defined (e.g. levels of 
infection and immunity). Thereafter, tests should be evaluated based on their ability to classify 
areas correctly into these states. The second is that any tests for widespread distribution, 
particularly indirect tests, should be developed so that their results are consistent from 
laboratory to laboratory and area to area. Thirdly, increased sensitivity is required for some but 
not all applications. 
There is still much to be learned about the epidemiology and improved control of 
trypanosomosis. Improvements in our understanding will depend on better study design, more 
intelligent and consistent application of existing diagnostic methods, and, in some 
circumstances, development, standardisation and evaluation of newer methods. 
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Development, standardisation and validation of enzyme 
immunoassays: an integrated process 
P.F. Wright 
Agriculture and Agri-Food Canada, National Centre for Foreign Animal Disease  
Federal Laboratories, 820 Elgin Avenue, Winnipeg, Manitoba, Canada, R3E 3M2 
Summary 
The development, standardisation and validation of an enzyme immunoassay should be viewed 
as an integrated and ongoing process which requires comprehensive planning from the onset 
and critical evaluation at various stages along the way. Specific requirements in terms of 
analytical criteria, diagnostic performance, standardisation, quality assurance, data expression, 
production, technology transfer and validation need to be considered. This necessitates input 
and cooperation from appropriate research, production, diagnostic, field and programme 
groups. Without this type of integrated approach, the likelihood that some factor will be 
overlooked is virtually guaranteed. A small factor, which may seem insignificant in the early 
stages of the process, may prove to be a significant barrier to the final acceptance of an assay. 
Coordination of this process is not an easy task and it is best handled by a methods 
development team. This is the group that defines the above requirements and ensures that they 
are met. Based on a number of years' experience in methods development, the following 
discussion describes some of the less obvious factors which can make or break an enzyme 
immunoassay with respect to it becoming a valuable diagnostic asset. 
Introduction 
The virtues of the enzyme immunoassay (EIA) have been extolled for over a quarter of a 
century and need not be reiterated time and again. Advances in biotechnology, specifically 
monoclonal antibodies and recombinant antigens, have even further enhanced the potential of 
this technique. However, very few EIAs have made the successful transition from the research 
laboratory into the diagnostic laboratory. The reasons for this are numerous and, for the most 
part, are preventable. The development, standardisation and validation of an enzyme 
immunoassay should be viewed as an integrated and ongoing process. A process which 
requires comprehensive planning from the onset and critical evaluation at various stages along 
the way. Specific requirements in terms of analytical criteria, diagnostic performance, 
standardisation, quality assurance, data expression, production, technology transfer and 
validation need to be considered. This necessitates input and cooperation from appropriate 
research, production, diagnostic, field and programme groups. Perhaps the single greatest 
challenge is getting the appropriate people from the appropriate groups to work together in the 
planning and evaluation stages. The best approach to this is to form a methods development 
team with representation from all of the concerned groups. 
Considerations 
The following highlight a number of considerations which, if not properly addressed, may pose 
significant barriers to the usefulness and acceptance of an assay. Some may seem intuitively 
obvious but all are nonetheless important. 
Analytical criteria 
 Host species: application to single or multiple species may have an affect on assay 
design strategies and the need for species specific reagents (especially for antibody 
detection). 
 Immunoglobulins: detection of antibodies of certain immunoglobulin isotypes may be 
more diagnostically relevant than others (e.g. IgG1 vs. IgM). 
 Antigens: detection of some antigenic epitopes or antibodies against them may be more 
appropriate than others (e.g. group specific vs. serotype-specific epitopes). 
 Cross reactions: detection of cross reacting antigenic epitopes on other organisms or 
antibodies against them may lead to false positive reactions. 
 Vaccination: detection of persistent or residual antibody following vaccination may lead 
to false positive reactions (especially where vaccination programmes are not regulated). 
 Test Samples: nature and stability of the test sample and processing requirements may 
affect assay repeatability and reproducibility (especially for antigen detection). 
 Immunological reagents: choice of polyclonal vs. monoclonal antibodies may impact on 
analytical and diagnostic performance (i.e. analytical specificity and binding avidity). 
 Antigenic reagents: choice of crude, purified or recombinant antigens may impact on 
both analytical and diagnostic performance and on assay design (particularly for 
antibody detection). 
 Enzyme/substrate systems: some systems are more sensitive than others in terms of 
signal generation; this does not necessarily translate to enhanced diagnostic 
performance but rather may have a negative impact. 
 Assay design: all of the foregoing considerations may impact on the choice of assay 
design with respect to detection strategies (i.e. indirect, competitive, inhibition, blocking, 
capture, etc.). 
Diagnostic performance 
 Application: programme applications (for both antibody and antigen detection assays) 
should dictate diagnostic performance requirements (e.g. control, vaccination, 
elimination, surveillance, import/export, survey, treatment, etc.). 
 Interpretation: level of interpretation should be considered (e.g. herd or individual animal 
levels); interpretation with or without other test results may affect diagnostic performance 
(e.g. serial or parallel interpretation). 
 Diagnostic sensitivity: a minimum, acceptable diagnostic sensitivity target should be 
established based on application and interpretation. 
 Diagnostic specificity: a minimum, acceptable diagnostic sensitivity target should be 
established based on application and interpretation. 
 Prevalence: prevalence of infection or disease and the impact of false positive or 
negative results may impact on minimum targets for sensitivity and specificity. 
Standardisation 
 Biological reagents: international reference standards should be used; if unavailable, 
standards should be created and characterised for future reference and assay 
calibration; standards should be the basis for the development of internal controls. 
 Buffer systems: standard buffer systems (composition, pH, ionic strength) and 
detergents should be adopted for wash, diluent and substrate buffers; addition of 
biological blocking agents should be avoided unless absolutely necessary. 
 Physical parameters: storage conditions and volumes, dilution factors, incubation times 
and temperatures, wash cycles, plate shaking, batch processing, etc. should suit the 
assay application with respect to volume of tests to be performed and expected turn 
around time for results. 
 Microplates: microplates chosen should be of consistent batch-to-batch quality and 
preferably from the same manufacturing facility; for some applications, good quality 
untreated plates may be better than treated (i.e. high protein-binding capacity) plates. 
 Water quality: minimum standard should be established and performance of reference 
reagents and internal controls should be characterised under these conditions; changes 
in water quality may first be evident in the activity of internal controls. 
 Equipment: equipment used for development should be the same or equivalent to 
equipment used in the diagnostic laboratory (e.g. of the same quality, accuracy and 
precision). 
 Suppliers: for all of the above, sufficient information should be documented to allow 
diagnostic laboratory to obtain identical or equivalent materials and equipment (e.g. 
chemical grade, pipette specifications, etc.). 
 Protocols: a standard format for assay protocols should be adopted; all of the above 
information should be included in the protocols; protocols should meet International 
Standards Organization (ISO) guidelines. 
Quality assurance 
 Biological reagents: should be stable upon shipping and storage; method of 
preservation, shelf-life and special handling instructions should be documented. 
 Buffer systems: acceptable pH ranges, shelf-lives and storage conditions should be 
documented. 
 Physical parameters: acceptable ranges for times, temperatures, etc. should be 
documented. 
 Internal controls: should cover the range of expected reactions, including strong, weak 
and negative reactions; results should always be unequivocal with respect to 
positive/negative status; upper and lower control limits should be established in 
diagnostic laboratory setting. 
 Acceptance criteria: acceptance of a given plate or run should be established based on 
the performance of the internal controls; clear criteria should be documented; final 
decision should be a `human' decision. 
 Test samples: acceptance of test sample results should also be defined; clear criteria 
are required for reactivities near the positive/negative cut-off; in some assays, a 
suspicious zone may be appropriate. 
 Control charts: daily control charts of internal controls should be kept and used to 
monitor process control and developing trends. 
 Proficiency testing: where possible, external check sample programmes should be 
implemented and used to certify or recognise diagnostic laboratory proficiency. 
 Protocols: all of the above information should be included in the assay protocols; 
protocols should meet International Standards Organization (ISO) guidelines. 
Data expression 
 Choices: for some applications, qualitative data (e.g. positive or negative) may be 
appropriate; for others, quantitative or semi-quantitative data may be more suitable (e.g. 
percent inhibition or percent positivity); raw data (e.g. absorbency values) are not 
comparable between laboratories. 
 Reference standards: internal controls should be calibrated against reference standards; 
data should be expressed relative to calibrated, internal control (e.g. strong positive 
antibody standard in the indirect ELISA or monoclonal antibody control in competitive 
type assays). 
 Cut-off: should be expressed in the same manner as test data (i.e. percent inhibition or 
percent positivity); cut-off values should be established as part of the field validation 
process. 
 Laboratory interpretation: reactivity status should be based on analytical and quality 
assurance criteria; additional interpretation may be required if serial or parallel testing is 
performed. 
 Field interpretation: reported data must be in a format which is acceptable to and easily 
interpreted by field staff; no internationally adopted formats exist for ELISA's, although 
some have been proposed for antibody assays. 
Production 
 Protocols: should be documented for the production of all biological materials, including 
antigens, antibodies, conjugates, controls and panels; protocols should include 
production details, standardisation processes and quality assurance checks. 
 Schedules: should be established with respect to production frequency and batch 
requirements, including quantity, titer, aliquot size, safety tests, preservation methods 
and expiry. 
Technology transfer 
 Scope: should suit target groups and general level of laboratory proficiency; both 
technical and scientific staff may require training; more than one session may be 
required. 
 Troubleshooting: target laboratories should be surveyed with respect to deficiencies in 
utilities, equipment, supplies, personnel, etc. and corrective actions should be 
recommended. 
 Proficiency: as part of the technology transfer process, an external check sample 
programme should be established to certify diagnostic laboratories as proficient or 'ready 
to perform'. 
 Backstopping: contingencies should be established to assist laboratories which 
experience unforeseen problems with assay performance. 
Validation 
 Design: should suit the intended application of the assay with respect to target 
population(s); sample sizes should give appropriate confidence for estimates of 
diagnostic sensitivity and specificity. 
 Definition: test populations should be realistic and clearly defined; `text book' groupings 
may not be achievable. 
 Testing site(s): ideally, validation should be conducted under routine diagnostic 
laboratory conditions and in more than one laboratory. 
 Cut-off: should be established after the testing of defined populations; method of 
analysis should be compatible with method of data expression; one cut-off may not be 
suitable for all laboratories depending on background activity associated with local test 
populations. 
 Prevalence: cut-off values may require readjustment as the prevalence of disease 
changes; in general cut-off values and prevalence are inversely related. 
 Other factors: validation should not only include estimates of diagnostic performance but 
assay accuracy, precision, repeatability and reproducibility as well. 
 Monitoring: validation should be a continuous process which requires constant 
monitoring, assessment and updating at the diagnostic laboratory level. 
Conclusion 
As may be seen in the foregoing 50 or so points, the development, standardisation and 
validation of an enzyme immunoassay is a complex and integrated process. Undoubtedly other 
points may be added to the list, but the preceding serves to illustrate that this process requires 
comprehensive planning from the outset and critical evaluation at various stages along the way. 
Confidence in the assay by diagnostic laboratory, programme and field personnel is critical to its 
acceptance and use. One weak link in the process and confidence may be jeopardised. In order 
to ensure a smooth transition, a methods development team must ensure that all of the 
potentially critical points, as minor as some may seem, have been addressed. 
  
Ag-ELISAs for trypanosomes 
Antigen-ELISA for detection of trypanosomes 
R.A. Masake and S.H. Minja 
International Livestock Research Institute P.O. Box 30709, Nairobi, Kenya. 
Summary 
Diagnosis is essential in the management of disease, both at the level of individual animal and 
at the level of disease control in populations. The routinely employed methods for detection of 
trypanosomes are capable of revealing infection during the acute phase but as the disease 
becomes chronic, the power to detect parasites greatly reduces. This led to development and 
application of a new and more appropriate technique for diagnosis of African trypanosomes. 
Sensitive and easy to perform antigen-detection ELISAs, based on monoclonal antibodies 
(MAbs), raised against trypanosome species have been developed. The performance of these 
assays has been evaluated both in the laboratory and field and found to be more sensitive than 
the routinely applied parasitological assays. The sensitivity of these assays is not optimal and 
requires further refinement to enable them to detect, if possible, all the parasitaemic cases. 
Steps have been taken to achieve this but the changes likely to improve the performance of the 
assays have not yet been effected. The specificity of the monoclonal antibodies in capturing 
trypanosome antigens was evaluated using bovine sera obtained from trypanosomosis-free 
areas and shown to be over 92 per cent specific. 
Introduction 
Trypanosomosis is a major constraint to livestock production in sub-Saharan Africa and to a 
lesser extent in Latin America and Asia. The distribution of the disease is influenced by the 
existence of tsetse and biting flies. Tsetse-transmitted trypanosomosis is encountered in 39 
sub-Saharan African countries. The non-tsetse transmitted trypanosomosis occurs in Latin 
America, Middle East, Asia, Eastern Europe and to a lesser extent Africa. 
Trypanosomosis, a disease of man and livestock, is endemic in much of tropical Africa. The 
trypanosomes responsible for the disease in domestic animals belong to several species which 
includeTrypanosoma congolense, T. simiae, T. vivax, T. brucei, T. evansi and the sexually 
transmitted T. equiperdum. Among these, T. vivax and T. evansi are the most widely spread, 
since they occur not only in tropical Africa, but also in South America (Applewhaite 1990; Shaw 
and Lainson 1972; Wells 1984) and southeastern Asia (Boid and Mleche 1985). Trypanosoma 
evansi causes disease in horses, camels, pigs, buffaloes and cattle, while T. equiperdum affects 
horses and donkeys. Typically, trypanosomosis in livestock is characterised by anaemia, weight 
loss, compromised immunological and endocrinological functions and waves of parasitaemia 
(Losos and Ikede 1972; Masake 1980). The disease syndromes associated with T. 
vivax infections vary from acute and fatal disease seen in West Africa, to relatively milder forms 
of infection of cattle in East Africa. However, in the latter region, some stocks of T. vivax cause 
a severe haemorrhagic disseminated intravascular coagulation (DIC)-like syndrome (Assoku 
and Gardiner 1989). 
Thus, there appears to be no consistent set of clinical signs to facilitate diagnosis of 
trypanosome infections. In view of this, microscopy has been employed traditionally in the 
positive identification of the causative organism (Woo 1971; Murray et al 1977). Standard 
diagnostic techniques applied in the detection of trypanosome infection are heavily dependant 
on the identification of the parasite in accessible body fluids of infected animals. The easiest of 
the parasitological techniques used is the direct microscopic examination of wet blood film or 
stained blood smears for the presence of trypanosomes. Detection of parasites in wet blood 
films allows speciation on the basis of motility while examination of Giemsa-stained blood 
smears makes classification on the basis of morphology possible. Although these techniques 
are easy to perform, their sensitivity is poor. In an effort to improve the sensitivity of the direct 
microscopy, Woo (1971) introduced the microhaematocrit technique (Woo technique) in which 
trypanosomes are concentrated at the vicinity of the buffy coat. Further improvements of the 
technique was achieved by cutting the micro-capillary tube and exuding the buffy coat and 
adjacent red blood cells onto a microscope slide. The contents are subsequently examined 
under phase contrast/dark ground microscopy to identify trypanosomes (Murray et al 1977). 
This modification, often referred to as buffy coat technique, is useful in detection of T. 
congolense which tends to stick to red cells unlike the Woo technique which is better in the 
detection of T. brucei.Other concentration methods in use involve removal of blood cells either 
by lysing them or by anion exchange chromatography. Despite all the modifications introduced, 
the paucity of trypanosomes in the blood of chronically infected animals limits the use of the 
parasitological techniques alone in diagnosis. This has proved to be notoriously difficult in field 
studies designed to examine the prevalence of trypanosomosis (Nantulya 1990). These 
shortcomings necessitated the development of alternative diagnostic techniques, one of which 
is an antibody detection ELISA (Nantulya 1990; Luckins 1977). These assays provide 
information about exposure of animals to the parasite, but cannot differentiate current from past 
infections. 
Antigen-detection enzyme-linked immunosorbent assay (Ag-ELISA) 
Tremendous efforts have gone into the development of highly sensitive and specific diagnostic 
techniques, which detect current infections. To do this, species-specific monoclonal antibodies 
(MAbs) were generated based on the hybridoma technology. Monoclonal antibodies have been 
raised against non-variable trypanosomal antigens which distinguish between T. brucei, T. 
congolense and T. vivax (Nantulya et al 1987). Monoclonal antibodies reacting with T. 
congolense and T. vivax are species-specific while those capturing T. brucei antigens have 
been found to react with T. b. gambiense, T. b. rhodesiense, T. evansi and T. equiperdum. The 
MAb raised against the Trypanozoon group of parasites recognises an antigen on the plasma 
membrane whose epitope is resistant to periodate oxidation (Nantulya and Lindquist 1989). 
These genus- and species-specific MAbs have been incorporated into an antigen-trapping 
ELISA for detecting trypanosome antigens in the blood of infected animals and human patients. 
In cattle the MAbs capture trypanosome antigens in blood before or coinciding with the onset of 
parasitaemia. The trypanosome antigens have been shown to increase and persist in the blood 
even when parasites were not demonstrable by the haemoconcentration techniques (Figure 1; 
Nantulya and Lindquist 1989; Masake et al 1991, 1995). The ability of the assay to detect 
infections associated with very low numbers of parasites in circulation has facilitated its use in 
revealing presence of the trypanosomes in chronically infected animals. To assess the 
specificity of the Ag-ELISA, serum samples were obtained from aparasitaemic goats residing in 
areas known to be either endemic with or free of trypanosomosis. These were examined for the 
presence of trypanosome antigens. Out of 131 samples collected from goats in endemic areas, 
106 were positive for trypanosome antigens, while all the 24 sera from trypanosome-free 
regions were negative on Ag-ELISA (Figure 2). The sensitivity of a monoclonal antibody-based 
Ag-ELISA for the diagnosis of T. congolense was evaluated using sera from experimentally 
infected goats and cattle. Ten goats (Galla × East African Maasai) and seven steers (Bos 
indicus) were infected with different clones of T. congolense and left to run a chronic course for 
46 and 24 months, respectively. During this period, monthly blood samples were collected and 
analysed for the presence of trypanosomes and their antigens in peripheral blood. Of 383 
caprine blood samples examined, 361 were positive for circulating antigens whereas only 43 
had demonstrable trypanosomes as revealed by the microhaematocrit centrifugation technique. 
In cattle, 570 (82%) out of 691 blood samples were Ag-ELISA positive compared to 136 (20%) 
samples with detectable trypanosomes (Table 1; Masake and Nantulya 1991). 
 
Figure 1. Comparison of the sensitivity of the antigen-ELISA and the buffy coat technique (BCT) 
in the diagnosis of Trypanosoma congolense infection in goat number 0–474. A mouse 
inoculated with blood from the goat 176weeks post-infection became infected 
with T.congolense parasites. Note the persistence of trypanosome antigens in the absence of 
dectable parasitaemia. Optical density (OD) values of 0.05 and above were considered positive. 
Similarly, sensitivity of Ag-ELISA for T. brucei was evaluated by infecting four Boran cattle 
with T. brucei using Glossina morsitans centralis and which were left untreated throughout the 
experimental period of 18 months. During this period, sequential blood samples were collected 
and examined for the presence of anti-trypanosome antibodies and trypanosome antigens. 
Using the microhaematocrit centrifugation technique, trypanosomes were detected in 38 of the 
233 (16%) blood samples. Unlike the microhaematocrit centrifugation technique, Ag-ELISA 
diagnosed infections in 189 (81%) of the blood samples (Table 2; Masake et al 1995). 
 Figure 2. The ability of Tc39-based Ag-ELISA to capture trypanosome antigens in (a) field sera 
obtained from aparasitaemic goats residing in a trypanosomiasis endemic area and (b) a 
trypanosomosis-free area. Note the high proportion of Ag-ELISA positive sera from the endemic 
area as opposed to those negative in trypanosomosis-free area. Optical density (OD) values of 
0.05 (interrupted horizontal line) and above were regarded as positive. 
The ability of Tc39-based Ag-ELISA to capture trypanosome antigens in field sera obtained from 
aparasitaemic goats residing in (a) a trypanosomosis-endemic area and (b) a trypanosomosis-
free area. Note the high proportion of Ag-ELISA positive sera from the trypanosomosis-endemic 
area as opposed to those negative in trypanosomosis-free area. Optical density (OD) values of 
0.05 (interrupted horizontal line) and above were regarded as positive. 
Table 1. Comparison of the sensitivity of antigen-ELISA and the buffy coat technique (BCT) in 
the detection of infections in cattle experimentally infected with T. congolense. 
Animal No.  
Number of samples 
tested 
Number positive by 
BCT (%) Ag-ELISA (%) 
D532 99 26 (26) 76 (77) 
D533 99 18 (18) 89 (90) 
D534 99 8 (8) 61 (62) 
D538 98 29 (30) 94 (96) 
D541 97 22 (23) 76 (78) 
D542 99 11 (11) 85 (87) 
D638 100 22 (22) 89 (89) 
Total 691 136 (20)  570 (83) 
Table 2. Comparison of the sensitivity of antigen-detection ELISA and the buffy coat (BCT) in 
diagnosing T. brucei infection in experimentally infected cattle. 
Animal No.  
Number of samples  
tested 
Number positive  
by BCT (%)  
Ag-ELISA (%) 
BH329 57 14 (25) 46 (81) 
BH346  59 8 (14) 34 (58) 
BH347  59 8 (14) 53 (90) 
BH349  58 8 (14) 56 (97) 
Total 233 38 (16) (189) (81) 
Further, an Ag-ELISA based on monoclonal antibody specific for Trypanozoon group was tested 
for its reactivity with T. b. gambiense (Nantulya et al 1992) and T. b. rhodesiense (Nantulya 
1989; Komba et al 1992; Gichuki et al 1994). Cerebral spinal fluid (CSF) and sera were 
collected from human clinical cases of T. b. gambiense sleeping sickness in Daloa and 
Kinshasa clinics. The sera and CSF from parasitologically confirmed cases were examined by 
Ag-ELISA for the presence of trypanosomes. Out of 265 cases, 241 were positive (91%) on Ag-
ELISA. In four of these Ag-ELISA positive cases, trypanosome antigens were found only in the 
CSF (Nantulya et al 1992). Clearance of trypanosome antigens in the peripheral blood and CSF 
occurred following chemotherapeutic intervention. Control sera for the evaluation of the assay 
were obtained from 165 blood donors and 40 patients with malaria, 2 with hydatidosis and 12 
with leishmaniasis. The optical density (OD) reading of these sera on Ag-ELISA all fell below the 
cut off OD 0.05. 
The performance of the Ag-ELISA in revealing T. b. rhodesiense infections was evaluated in 
humans and monkeys (Komba et al 1992; Gichuki et al 1994). In the case of human 
trypanosomosis, 363 patients seen in four different clinics in Uganda, Tanzania and Zambia with 
detectable parasites either by thick blood film, haematocrit centrifugation technique, miniature 
anion-exchange chromatography or on single and double centrifugation of CSF were examined 
by Ag-ELISA for the presence of circulating trypanosome antigens. Three hundred and thirty-
two out of 363 were positive on Ag-ELISA. This represented a detection rate of approximately 
92%. More importantly, no cross reactivity with bacterial, viral and parasitic diseases prevailing 
in these areas was observed in 111 patients. However, out of 20 blood donors residing in an 
area known to be endemic for trypanosomosis one was positive on Ag-ELISA (Komba et al 
1992). Prior to the above study, 375 blood donor sera from Uganda were examined and shown 
to be negative on Ag-ELISA using the recommended dilution factor and no cross-reactivity 
occurred with sera from either 10 leishmaniasis, 17 schistosomiasis or 23 malaria patients 
(Nantulya 1989). However, when 211 serum samples from clinically suspected cases of 
trypanosomosis were subjected to Ag-ELISA, 136 were positive (64%). All of these patients 
were negative by all the parasitological tests employed. Hence Ag-ELISA can serve as a 
complementary test to parasitological diagnosis as well as assist in obtaining correct diagnosis 
at certain stages of the disease. Furthermore, the assay can be employed in the assessment of 
efficacy of trypanocidal drugs (Gichuki et al 1994). 
Trypanosome antigens captured by the monoclonal antibodies 
applied in Ag-ELISA 
Trypanosoma vivax-specific antigen recognised by monoclonal antibody Tv27 is a 10 kDa 
protein. The protein is diffusely distributed throughout the cytosol and nucleus of metacyclics, 
bloodstream form parasites and procyclic-like elongated trypomastigotes, but was not 
detectable in the epimastigotes of T. vivax. The gene encoding the 10 kDa protein has been 
isolated and sequenced. The gene is repeated in tandem with a monomeric unit length of 900 
bp. Amino acid analysis did not reveal any significant identity with any known proteins. Thus the 
function of this protein is unknown. 
The monoclonal antibody (Tc38.51 and Tc39) for capturing T. congolense antigens recognises 
a protein doublet of 38/40 kDa. The antigen is expressed by all stages of T. congolense. The 
gene encoding this antigen was identified, isolated and sequenced. The DNA isolated was 1.8 
kb. The size of hybridising genes varied in size from one isolate to another giving sizes such as 
2.8, 3.6, 5.4, and 6.6 kb. These sizes were suggestive of a tandemly repeated cDNA. This was 
subsequently proven using a time course digestion of genomic DNA derived from different types 
of T. congolenseand shown to exhibit 20–30 repeats. The DNA insert obtained hybridised to 
the T. congolense genome but not to that of T. vivax. Cross reactivity was observed with the T. 
brucei genome at low stringency washings (Jaye 1993). 
Amino acid analysis of the gene revealed extensive homology (96%) with another T. 
congolense cysteine protease sequenced by Fish et al (1995). It is apparent that there is a 
family of cysteine proteases within the Nannomonas group. Furthermore, there was a 69% 
homology with a cysteine protease isolated from T. b. brucei and 70% identity to that of T. b. 
rhodesiense (Pamer et al 1990). 
Trypanosoma brucei antigen captured by the Tr7 monoclonal antibody has not been isolated. 
Nevertheless, the antigen captured is located on the plasma membrane and the epitope 
recognised is a protein since it is resistant to periodate oxidation. 
New generation of monoclonal antibody-based Ag-ELISA 
Despite the high sensitivity displayed by Ag-ELISA, false negatives were sometimes observed 
in the presence of detectable parasitaemia. This was particularly evident in the field validation 
report obtained from Mali (Bamako) whilst the field studies carried out in Uganda recorded less 
than 9.3% false negatives. In order to improve further the sensitivity of Ag-ELISA IgG1 isotype 
monoclonal antibodies have been made. Studies conducted using IgG1 monoclonal antibodies 
derived against Trypanozoon groups T43 and T. congolense (Tc38.51)-specific in the laboratory 
yielded similar results to those obtained using IgM (Tr7 and Tc39) isotypes. The sensitivity of 
MAb T43 ranged from 32% to 90% when tested on serial serum samples recovered from 
individual animals but gave an average sensitivity of 70% as opposed to 37% obtained on 
parasitological examination. 
Bovine serum samples were collected from a trypanosomosis endemic area and examined for 
the presence of T. brucei antigens. Of 80 samples, 26 had detectable trypanosome antigens; 
when a similar exercise was conducted on 80 bovine sera obtained from a trypanosome-free 
region, all results were negative. Studies on the T. congolense Ag-ELISA based on Tc38.51 
yielded data similar to that of Tc39 (IgM isotype currently in use). Reactivity of Ag-ELISA based 
on Tc39 (IgM) and Tc38.51 (IgG) were compared on 80 bovine sera from each of the areas 
endemic for, or free of, trypanosomosis; 18 out of the 80 sera from the endemic area were 
positive for the two MAbs and none of the sera from trypanosomosis-free area was positive. 
These studies were expanded and the new and original monoclonal antibodies tested on 200 
serum samples obtained from Kapiti plains. The farm, which is located next to the main highway 
connecting the Kenya coast and Nairobi, is believed to be free from trypanosomosis. The four 
monoclonal antibodies were examined for their specificity in capturing trypanosome antigens on 
the 200 bovine sera as shown in Table 3. The results obtained indicate a slightly higher 
specificity (98.5 and 99.5%) for the IgG1 isotype when compared to the IgM (92.5 and 95%). 
Table 3. Specificity of T43, Tr7, Tc38.51 and Tc39 in capturing trypanosome antigens in bovine 
sera obtained from Kapiti plains. 
Mabs Isotype 
No. of   
bovine sera 
No. of   
positive sera  
No. of   
negative sera 
Specificity of   
the MAbs (%) 
T43 IgG1 200 1 199 99.5 
Tr7 IgM 200 10 190 95.0 
Tc39 IgM 200 15 185 92.5 
Tc38.51 IgG1 200 3 197 98.5 
Table 4. The sensitivity of Ag-ELISA based on T43, Tr7, Tc38.51 and Tc39 when used for 
trapping trypanosome antigens in bovine sera obtained from 4 trypanosome endemic areas 
Origin 
No. of 
samples 
No. and percentage of sera positive by Ag-ELISA based on 
Apatit 72 57 (79%) 15 (21%) 12 (17%) 59 (82%) 
Katelenyang’ 96 71 (74%) 27 (28%) 30 (31%) 85 (89%) 
Ng’elechom 163 95 (58%) 26 (16%) 35 (21%) 138 (85%) 
Rukada 181 22 (12%) 70 (39%) 70 (39%) 129 (71%) 
Subsequently more bovine sera were obtained from endemic areas, namely Apatit, 
Katelenyang', Ng'elechom and Rukada. These were assayed for the presence of trypanosome 
antigens using ag-detection ELISA based on T43, Tr7, Tc38.51 and Tc39. This study showed 
that T43 is much more sensitive than Tr7 in the field while Tc39 trapped antigen in more sera 
than Tc38.51. It was even more interesting to note that Ag-ELISA based on T43 captured 
antigens in a high proportion of bovine sera obtained from cattle residing at Apatit, Katelenyang' 
and Ng'elechom, which are endemic for human sleeping sickness (Table 4). Furthermore the 
cattle found to be positive for T. brucei on parasitological test were also positive using T43-
based Ag-ELISA. The same correlation was observed between Tc39-based Ag-ELISA and the 
parasitological technique. 
The number of animals found to be harbouring trypanosome antigens using T43 were much 
less in Rukanda, a place not associated with human sleeping sickness. The field data would 
therefore suggest that T43 trapped Trypanozoon antigens since the specificity of the Ag-ELISA 
based on this Mab is approximately 99%. On the contrary Mab Tc38.51 performed poorly when 
compared to the IgM isotype (Tc39). Tc38.51 failed to trap antigens in most of the 
parasitologically positive cases of T. congolense. 
Steps taken to optimise the sensitivity of Ag-ELISA 
Attempts were made to improve the performance of Ag-ELISA by altering various parameters 
such as temperature, chromogen system and volume of test material in the reaction mixture. 
The assay is usually run at room temperature at ILRI. Change of temperature from prevailing 
room temperature to 37°C resulted in minimal increase in optical density reading. But when 
changes in temperature were combined with use of 3',3', 5',5'-tetramethylbenzidine (TMB) 
instead of Azino bis (3-ethyl)-benzthiazoline-6-sulphonic (ABTS), the increase in optical density 
readings were significant. Further increases in optical density readings were obtained when the 
volume of sera introduced into the microtiter plate was increased from 10 al to 40 al in a 
reaction volume of 100 al. This increase in volume of the test sample did not cause a rise in 
background reading as seen in the Figure 3. 
 Figure 3. Effect of volume on optical density (OD) readings. 
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Summary 
Following the initial development of an enzyme-linked immunosorbent assay (ELISA) at the 
International Livestock Research Institute (ILRI, formerly at ILRAD), the methodology and the 
monoclonal antibody producing hybridoma cell lines were transferred from ILRI to the Food and 
Agriculture Organization/International Atomic Energy Agency (FAO/IAEA) Agriculture and 
Biotechnology Laboratory in Seibersdorf. Subsequently, it was necessary to perform various 
assay adjustments in order to standardise and transform the assay to a kit form for distribution 
to research and diagnostic laboratories in Africa. Initial results on the sensitivity of the test were 
obtained by experimental infections in goats, while results from negative populations in the field 
were used for the assessment of the test specificity. Training of scientists in ELISA techniques 
and the transfer of the methodology was successfully achieved during the six years of a Co-
ordinated Research Programme funded by the Government of the Netherlands and executed by 
the Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture (1987–1992). 
During an additional two years the test was used in combination with standard parasitological 
techniques for monitoring tsetse and trypanosomosis control programmes with funding from the 
IAEA Technical Co-operation Department and the British Government (1993–1995). A second 
Co-ordinated Research Programme funded by the Netherlands Government has been initiated 
to develop and use improved antibody- and antigen-detection ELISA for the diagnosis of 
trypanosomosis and the monitoring of control and eradication programmes in Africa. 
Introduction 
The Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture, Vienna, Austria, 
operates the sub-programme of Animal Production and Health, which is one of five currently 
existing sub-programmes. Support for the operation of these sub-programmes is provided 
through five sections within the Joint FAO/IAEA Division and five units of the FAO/IAEA 
Agriculture and Biotechnology Laboratory in Seibersdorf. 
The mandate of the Animal Production and Health Sub-programme is to improve livestock 
production in developing countries through the support of problem-oriented research that 
identifies the constraints of production and develops cost-effective and sustainable solutions 
(using nuclear-based technologies). Improvements in animal health are approached by 
supporting the introduction and use of nuclear and related techniques in developing countries 
through Co-ordinated Research and Technical Co-operation Programmes. A Co-ordinated 
Research Programme (CRP) entitled 'Improving the Diagnosis and Control of Trypanosomosis 
and Other Vector-borne Diseases of African Livestock Using Immunoassay Methods' was 
executed from 1987 to 1992 with funding from the Directorate General of Development Co-
operation (DGIS) of the Government of the Netherlands. The International Livestock Research 
Institute (ILRI) in Nairobi, Kenya, succeeded in the development of enzyme-linked 
immunosorbent assay (ELISA) systems for the detection of cytoplasmic antigens 
of Trypanosoma congolense, T.vivax and T. brucei in cattle (Nantulya et al 1987). For the 
purpose of the CRP, a ready-to-use ELISA kit form was assembled, consumables and training 
were provided and small research projects for field validation of the ELISA were initiated. A 
network which originally consisted of 13, but was subsequently reduced to 11, national 
agricultural research systems (NARS) was set up with the active collaboration of ILRI and the 
Centre of Tropical Veterinary Medicine (CTVM) in the UK. The reports by the various research 
contract holders were compiled and published as a technical document (IAEA 1993) together 
with conclusions, recommendations and reports by experts in the field. The continuation of the 
programme will be briefly described with emphasis on the performance of the antigen-detection 
ELISA following the transfer of biological reagents from ILRI to the FAO/IAEA Agriculture and 
Biotechnology Laboratory, Seibersdorf, Austria in December 1992. 
Laboratory activities (1993–1996) 
Training and transfer of biological reagents and methodology 
ILRI developed monoclonal antibodies (MAbs) against the conserved, invariant, non-secreted 
internal antigens of tsetse fly transmitted T. brucei, T. congolense and T. vivax. The antigens 
are released upon parasite destruction. During the period from October to December 1992 a 
FAO/IAEA staff member undertook a scientific visit to ILRI to become familiar in the handling of 
hybridoma cell lines and in production and quality assurance aspects of specific monoclonal 
antibodies and conjugates used in the direct sandwich ELISA. Following the training period, the 
MAbs-producing hybridoma cell lines, trypanosome stabilates and the relevant methods were 
transferred to the FAO/IAEA Agriculture and Biotechnology Laboratory. 
Establishment of a cell culture laboratory and laboratory animal facilities 
At the laboratory's Animal Production Unit (APU), a cell culture laboratory and facilities for 
accommodation of mice, rats and rabbits for experimental purpose were established to provide 
technical capabilities that are crucial for quality assured routine bulk production of biological 
reagents. The laboratory has the capacity for 
 thawing, cryopreserving, and propagation of hybridoma cell lines including quality control 
of both cell lines and media components for, in particular, mycoplasma, IBR-, BVD-, 
BRS- and PI-3 virus contamination 
 production of MAbs in Balb/c mice ascitic fluid by injection of monoclonal antibody 
producing hybridoma cells (T.b.7/47.34.25 IgM anti-T. brucei; T.c. 39/30.38.11 IgM anti-
T. congolense; T.v. 27/9.45 IgG1 anti-T. vivax). Since this method is no longer accepted 
by the scientific community for ethical reasons, production methods have been changed 
to replace the in vivo system by an in vitro one recommended as the preferred method 
for routine bulk production of monoclonal antibodies 
 purification of MAbs using fast performance liquid chromatography (FPLC) system 
 production of direct-reporting monoclonal antibodies by conjugation of purified MAbs 
with horseradish peroxidase enzyme 
 sodium dodoecyl sulphate, polyacrylamide gel electrophoresis (SDS-PAGE) and 
Western immunoblot, as well as ELISA technique used for quality assurance of MAb 
production 
 propagation of trypanosome bloodstream forms in mice (T. vivax IL2160) and rats (T. 
brucei IL2616, T. congolense IL3266) 
 routine diagnosis of trypanosomosis by standard parasitological methods such as wet 
blood smears, Giemsa-stained thin and thick blood smears, micro haematocrit centrifuge 
technique and phase contrast/dark ground technique for microscopic examination of the 
buffy coat, separation of trypanosomes from blood by anion exchange chromatography 
column 
 preparation of trypanosome antigen lysates 
 experimental infection studies on goats/cattle to produce monospecific trypanosomal 
antigen reference serum samples and to assess diagnostic sensitivity and specificity of 
the direct sandwich ELISA. 
At the end of 1993, the MAbs and their conjugates produced at the APU were tested and cross-
referenced to those produced at ILRI to ensure that no aberrations occurred during the transfer 
of hybridoma cell lines to Seibersdorf. A comparative titration of these reagents performed 
according to the ILRI protocol of the antigen-detection ELISA indicated that the Seibersdorf-
produced reagents did not differ from the ILRI reagents. 
Table 1. Minor assay adjustments incorporated in the protocol of the FAO/IAEA direct sandwich 
ELISA for trypanosomal antigen detection. 
1 High binding plate (Nunc Immuno Plate MaxiSorpTM).  
2 Constant shaking for 15 minutes at 37°C.  
3 Control and test serum samples diluted 1:20.  
4 Addition to the serum diluent buffer of 0.5 % normal mouse serum as a liquid phase 
blocking agent. 
5 Addition to the conjugate diluent buffer of 1.0 % bovine serum albumin as a liquid phase 
blocking agent. 
6 Use of 3', 3' ,5', 5' tetramethylbenzidine chromogen and hydrogen peroxide 
7 Use of non corrosive 1M phosphoric acid as stopping solution. 
Assay adjustments 
In 1994, the APU's cell culture laboratory went into full-scale production of MAbs in ascitic fluid 
for use in the trypanosomosis ELISA kit. Minor adjustments as listed in Table 1 were 
incorporated in the protocol of the FAO/IAEA direct sandwich ELISA to increase the diagnostic 
specificity of the assay and improve the robustness of the test for use under laboratory 
conditions in Africa. Moreover, standardised internal quality control samples were incorporated 
including strong positive, moderate positive and negative antigen control, as well as conjugate 
control samples. All test samples were expressed as percent positivity relative to the strong 
positive antigen control, calculated by a computer software programme developed for the ELISA 
kit. 
In addition, the counterpart laboratories using ELISA technology were assessed for proficiency 
as part of the FAO/IAEA external quality assurance programme for diagnostic laboratories. 
ELISA sensitivity 
Two goats were experimentally infected with 1.5 × 108 T. vivax bloodstream forms. Blood 
samples were taken daily. The course of infection was assessed by determining the appearance 
of parasites and antigen in the systemic circulation, packed red cell volume (PCV) values, and 
rectal body temperature. When severe clinical symptoms were observed, the goats were treated 
with half the recommended dosage of Berenil® to induce chronic infection. 
Trypanosomes first appeared in both goats on day 5 post infection (pi), followed by antigen on 
day 5 pi (goat #20) and day 7 pi (goat #191), respectively. The presence of antigen detected by 
ELISA did not always coincide with the appearance of parasites detected by the buffy coat 
technique (BCT). After 83 days pi (goat #20) and 103 days pi (goat #191), neither parasites in 
goats #20 and #191 nor antigen in goat #20 were observed. Interestingly, goat #191 remained 
positive by ELISA until the end of experimental period (416 days pi). Optical density (OD) values 
were similar high to those previously observed at parasite-confirmed stages; false positive 
results might have been due to circulating anti-idiotypic antibodies produced during chronic 
infections. At certain stages of infection, the ELISA failed to give positive results although 
circulating trypanosomes were demonstrated microscopically. A full dosage of Berenil® for final 
treatment was administered on day 103 pi (goat #20) and day 125 pi (goat #191). On day 396 
pi, an induced relapse of parasitaemia and antigenaemia was unsuccessfully attempted by non-
steroidal drug treatment (Flurbiprofen®) over a period of seven days. The experiment was 
terminated at day 416 pi. For goat #20, the BCT sensitivity was 41.3% and the ELISA sensitivity 
30.7%. For goat #191, the diagnostic sensitivity of the BCT and the ELISA was 40.2% and 
45.1%, respectively. Although the results demonstrated that the ELISA used in combination with 
BCT improved the diagnosis of trypanosomosis in goats, the sensitivity of the test needed 
improvement. The low sensitivity of the test can be attributed to i) low concentration of detecting 
antibody used, ii) masking of trypanosomal antigens by host-produced antibodies forming 
immune complexes during the course of infection, and iii) competition of capture and detecting 
antibodies for the same T. vivax-specific epitope. 
In comparisons with other diagnostic techniques the results from positive cattle populations in 
tsetse-infested areas in Africa demonstrated that the ELISA was more sensitive than 
parasitological techniques in the detection of T. brucei but less sensitive in the detection of T. 
congolense or T. vivax. 
ELISA specificity 
The ELISA had a diagnostic specificity in the range of 94–100% using a cut-off value of 10 
percent positivity (T. brucei 96% ± 2%, T. congolense 99.5% ± 1%, T. vivax 99% ± 1%) when 
applied to negative cattle populations in tsetse-free areas in Africa. 
Training activities 
The FAO/IAEA direct sandwich ELISA was demonstrated at the FAO/IAEA/ILRI training course 
on 'Diagnostic Methods for Animal Trypanosomiasis', held from 16 May to 10 June 1994 at the 
International Livestock Research Institute (ILRI), Nairobi, Kenya and the FAO/IAEA inter-
regional training course on 'The Use of Immunoassay and Molecular Methods for Animal 
Disease Diagnosis and Control', held at Seibersdorf from 24 October to 25 November 1994. 
Furthermore, ELISA training was provided at the APU to researchers from Zanzibar on 
individual basis. 
Technical co-operation programme (TCP) RAF/5/028, 1993–1995 
Following the completion of the CRP which terminated at the end of 1992, the IAEA Department 
of Technical Co-operation and the Joint FAO/IAEA Division of Nuclear Techniques in Food and 
Agriculture provided support for a regional TCP (RAF/5/028) for an additional two years from 
mid-1993 to mid-1995. Financial assistance for this TCP was obtained from a voluntary 
contribution by the Overseas Development Agency of the United Kingdom (ODA-UK) and from 
funds allocated by the IAEA Department of Technical Co-operation for this purpose. The TCP 
assisted in strengthening disease diagnosis in nine national agricultural research systems 
(NARS) and supported the introduction of improved diagnostic techniques in five additional 
institutes. In addition, the TCP provided equipment to install serum banks, fellowships for 
additional training in data analysis and expert missions to resolve specific problems. The 
majority of the institutes that participated in the original FAO/IAEA CRP were assisted for an 
additional two years. At the initiation of the TCP, five institutes in Burkina Faso, Cameroon, Côte 
d'Ivoire, Ethiopia and Nigeria were added, while two institutes in Morocco and the Gambia were 
removed from the list of those being supported (Table 2). The shipment of FAO/IAEA direct 
sandwich ELISA kits to 14 research contract holders, and to Zanzibar (IAEA technical co-
operation project on tsetse fly eradication from the island using the sterile insect technique) was 
completed at the beginning of 1995. The scientific results obtained by the participants at the 
FAO/IAEA/ILRI epidemiology workshop on the monitoring of trypanosomosis and tsetse control 
programmes, held at the International Livestock Research Institute (ILRI) in Addis Ababa, 
Ethiopia, from 17–28 April 1995 have been published as an IAEA technical document (IAEA 
1997). 
Table 2. African institutes assisted by the IAEA department of technical co-operation through 
TCP RAF/5/028. 
Country Research institute Principal investigator 
Burkina Faso CIRDES  Z. Bengaly 
Cameroon LANAVET C. Ndamkou 
Côte d’Ivoire LANADA A. N’Depo 
Ethiopia NTTICC N. Tewelde 
Ghana Central Veterinary Lab. C. Doku 
Kenya KETRI W. Olaho-Mukani 
Mali Lab. Central Veterinaire O. Diall 
Nigeria NVRI S. Ajayi 
Senegal ISRA/LNERV M. Seye 
Sudan University of Khartoum E. Elamin 
Uganda LIRI N. Okuna 
United Republic of Tanzania ADRI H. Mbwambo 
Zambia CVRL L. Sinyangwe 
Zimbabwe CVL R. Ries 
Co-ordinated Research Programme (CRP), 1995–1999 
In 1995, the Directorate General of Development Co-operation (DGIS) of the Government of the 
Netherlands started funding the FAO/IAEA Co-ordinated Research Programme entitled 'The 
Use of an Immunoassay Method to Improve the Diagnosis of African Trypanosomosis and its 
Application to Monitor Disease Control Programmes' in which 15 research contracts (Figure 1) 
and four research agreements were awarded. The research agreement holders are scientists 
based at the University of Glasgow, Centre for Tropical Veterinary Medicine (CTVM) in 
Edinburgh, ILRI, Nairobi, and the Centre de coopération internationale en recherche 
agronomique pour le développement—départment d'élevage et de médicine vétérinaire 
(CIRAD-EMVT) in Montpellier. The shipment of FAO/IAEA direct sandwich ELISA kits to 15 
research contract holders, and to Zanzibar (IAEA technical co-operation project) was completed 
at the beginning of 1996. The results were presented at the first research co-ordinated meeting 
which was held from 9–13 September 1996 in Dakar, Senegal. 
 
Figure 1. African institutes participating in the joint FAO/IAEA Co-ordinated Research 
Programme (CRP), 1995–1999. 
The results confirmed the diagnostic specificity of the ELISA in the range of 90–100% using a 
cut-off value of 10 percent positivity. However, the sensitivity had not been improved. Therefore, 
a reassessment of the antigen-ELISA performance was recommended. The research contract 
holders received ELISA reagents to initiate the FAO/IAEA external quality assurance 
programme to assess individual laboratory proficiency. 
Conclusions 
ELISA technology was successfully established in 15 African laboratories belonging to the 
NARS. Consequently, an extensive network has become available for the application of an 
antigen-detection ELISA used in combination with parasitological techniques for improved 
diagnosis of trypanosomosis and monitoring trypanosomosis control programmes. Through the 
project initiated by the Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture, 
Vienna, Austria, various international research and diagnostic institutes in Africa have been 
assisted in the collection and analysis of ELISA and parasitological data from field and 
experimental studies during the past eight years. The results indicated that the diagnostic 
sensitivity of the ELISA was unsatisfactory compared with standard parasitological techniques. 
Therefore, the improvement and reassessment of the antigen-detection ELISA was initiated 
under supervision of a wider group of scientists. The group will be requested to prioritise and 
execute research activities for development of a new generation of immunoassays required for 
detection of anti-trypanosomal antibodies and trypanosomal antigens. 
References 
Nantulya V.M., Musoke A.J., Rurangwira F.R., Saigar M. and Minja S.H. 1987. Monoclonal 
antibodies that distinguish Trypanosoma congolense, T. vivax and T. brucei. Parasite 
Immunology 9:421–431. 
IAEA (International Atomic Energy Agency). 1993. Improving the diagnosis and control of 
trypanosomiasis and other vector-borne diseases of African livestock using immunoassay 
methods. IAEA-TECDOC–707. IAEA, Vienna, Austria. 
IAEA (International Atomic Energy Agency). 1997. Application of an immunoassay method to 
improve the diagnosis and control of African trypanosomosis. IAEA-TECDOC–925. IAEA, 
Vienna, Austria. 
  
Evaluation of Ag-ELISA in the field 
Sensitivity and specificity of antigen-ELISAs for diagnosis 
of Trypanosoma congolense and Trypanosoma 
vivax infections in cattle 
M.C. Eisler¹, P. Lessard², A.S. Peregrine², D. Moloo² and R.A. Masake² 
1. Department of Veterinary Physiology University of Glasgow Veterinary School 
Bearsden Road, Glasgow G61 1QH, UK 
2. International Livestock Research Institute  
P.O. Box 30709, Nairobi, Kenya 
Summary 
Sensitivity and specificity of the Food and Agriculture Organization/International Atomic Energy 
Agency (FAO/IAEA) antigen-ELISA kits for diagnosis of bovine trypanosomosis were 
investigated using sera from cattle experimentally infected by tsetse challenge with cloned 
populations of Trypanosoma congolense (three populations) or T. vivax (one population). The 
kits are based on monoclonal antibodies that recognise internal antigens of tsetse-transmitted 
trypanosomes. In general, while overall specificities were high, sensitivities of the antigen-
ELISAs were poor. For example, at a cut-off of 5% positivity, the sensitivities of the antigen-
ELISAs were 11% for samples (n=1162) from T. congolense-infected cattle (n=30), and 24% for 
samples (n=283) from T. vivax-infected cattle (n=10). The corresponding specificity values were 
95 and 79%, respectively. At a cut-off of 2.5% positivity, sensitivity for T. congolense was 25%, 
and for T. vivax 35%; corresponding specificity values were 85 and 63%, respectively. There 
were no values of the positive-negative threshold at which both sensitivity and specificity were 
satisfactory. Restricting the analyses to samples taken more than two weeks after tsetse 
challenge did not improve sensitivity estimates. Trypanosome species-specificities of the 
antigen-ELISAs were also poor. In contrast to the antigen-ELISA, the sensitivity of the buffy coat 
technique when applied to the same experimental animals was fairly high at 67% for T. 
congolense infections and 60% for T. vivax infections. For samples taken more than two weeks 
after tsetse challenge, high sensitivity estimates of 96% for T. congolense and 76% for T. 
vivax infections were obtained. 
Introduction 
The FAO/IAEA trypanosomosis direct antigen-ELISA kit has been distributed to scientists 
holding research contracts under an IAEA co-ordinated research programme in 14 sub-Saharan 
African countries. It is intended for improved diagnosis of bovine tsetse-transmitted 
trypanosomosis as an aid to epidemiological studies and to national trypanosomosis control 
programmes. The method was developed at the International Livestock Research Institute's 
Nairobi laboratories by Nantulya and Lindqvist (1989), and subsequently modified at the Animal 
Production and Health Unit at the IAEA Agriculture Laboratory, Seibersdorf, Austria. The most 
significant of these modifications are: 
 use of a blocking agent (0.5% normal mouse serum) in the sample diluent buffer 
 use of the chromogen 3,3', 5,5' tetramethylbenzidine (TMB) in place of ABTS 
 use of the percentage positivity data expression system 
 incorporation of internal quality assurance target values 
In spite of these modifications, the basic assay configuration remains the same as that of 
Nantulya and Lindqvist (1989). The anti-trypanosomal monoclonal antibodies are from the 
original hybridoma cell lines (derived at ILRI), and are used in the original assay configuration. 
In the work described here, the sensitivity and specificity of the FAO/IAEA trypanosomosis 
direct antigen-ELISA kit were assessed in relation to trypanosome infections in cattle. ELISA 
responses were measured in serum of previously naive cattle following primary experimental 
infection with cloned populations of Trypanosoma congolense and T. vivax originating from 
geographically distinct locations in East and West Africa. 
Materials and methods 
Experimental cattle 
Fifty-six Boran cattle (Bos indicus) aged 12 to 18 months, were obtained from ILRI's breeding 
herd at Kapiti Ranch on the Athi Plains, a trypanosomosis non-endemic area of Kenya. Cattle 
were loose-housed with free access to drinking water, and fed on hay and concentrates. Cattle 
infected with T. vivax and their uninfected cohorts were housed similarly, but in fly-proof 
accommodation. 
Trypanosomes 
Three cloned populations of T. congolense, representing parasites isolated in different locations, 
and one cloned population of T. vivax were used for infection of cattle. These were T. 
congolense IL 2642 originating from Uganda (Morrison et al 1978, 1982); T. congolense IL 1180 
(Geigy and Kauffmann 1973; Nantulya et al 1984) from Tanzania; T. congolense IL 2281 from 
Nigeria (Moloo and Kutuza 1988); and T. vivax IL Dat 1.2 derived from an isolate made in 
Nigeria (Gardiner et al 1986). 
Infection of cattle 
Cattle were infected by the application of five infective Glossina morsitans centralis to the skin of 
the flank. Six weeks before infection of cattle, goats were inoculated intramuscularly with one of 
the four trypanosome populations. Twelve to fourteen days later, trypanosomes were detected 
in peripheral blood. After another seven days, teneral G. m. centralis were fed daily on the 
infected goats for 25 days. Flies were then starved for two days prior to examination for infection 
by microscopic examination of salivary probes. Tsetse flies with metacyclic trypanosomes in 
their saliva were used to challenge cattle. 
Parasitological monitoring 
Cattle were examined for the presence of trypanosomes in the circulation by the phase contrast 
buffy coat technique (Murray et al 1977), using blood collected into EDTA vacutainers (Becton-
Dickinson), and an SM Lux microscope (Leitz, Wetzlar, Germany) with a 25 × magnification 
phase contrast objective. Care was taken to ensure that every microscopic field of the buffy 
coats was examined thoroughly. 
Collection and separation of serum 
Whole blood samples were collected from the cattle by jugular venipuncture into 10 ml 
siliconised plain vacutainers (Becton Dickinson) and incubated for four hours at 37°C to 
maximise clotting. Samples were then incubated at 4°C overnight, after which they were 
centrifuged at 1200 g for 15 min at 4°C, and serum aspirated. This procedure resulted in the 
maximum yield of serum, and no visible haemolysis. 
Experimental design 
Experiments were conducted using a double-blind system: neither those collecting the samples 
nor those conducting subsequent analyses knew which animals were infected and with which 
parasites until completion of the experiment. 
In each of four groups of 14 cattle, ten cattle were infected with trypanosomes, while the 
remaining four cattle were uninfected controls. Within each group, all ten infected cattle were 
infected with a single trypanosome population; group 1 with T. congolense IL 2642, group 2 
with T. congolense IL 1180, group 3 with T. congolense IL 2281 and group 4 with T. vivax IL Dat 
1.2. 
Beginning the day after application of tsetse flies, parasitological examination was conducted 
daily for three weeks, and bi-weekly thereafter until the following number of days after initiation 
of infections: groups 1 and 2, 108 days; group 3, 60 days; group 4, 67 days. Blood samples for 
separation of serum were collected on the same days as parasitological examination. 
Individual cattle were removed from the experiment if either the PCV fell below 14% or their 
clinical condition warranted removal on welfare grounds. 
Double-blind sample encryption and storage of serum 
Two aliquots (each 2 ml) of serum were stored in racks at -70°C in cryovials (Greiner). A 
random number coding system was used for the identification of the serum samples; the 
cryovials were labelled only with their unique code numbers. The identity of infected and control 
cattle were not revealed to individuals responsible for collection or subsequent testing of 
experimental samples. 
Antigen-ELISA 
Trypanosome Ag-ELISA was conducted using the FAO/IAEA Trypanosome Antigen-ELISA kits 
(serial numbers TRP95/GLA/01, TRP95/GLA/01, TRP95/06/18) provided by the FAO/IAEA Joint 
Division for Nuclear Techniques, Vienna, in accordance with the kit manual. The monoclonal 
antibodies contained in these kits were: 
        T. brucei             T.b.r.7 (IgM)  
        T. congolense    T.c.39 (IgM)  
        T. vivax               T.v.27 (IgG1) 
Briefly, the FAO/IAEA kit protocol was as follows: 
Maxisorp (Nunc) 96-well polystyrene microtitre plates were coated overnight with 100 µl per well 
of monoclonal antibody (T.b.r.7, T.c.39 or T.v.27) diluted to 3.3 µg/ml in 50 mM carbonate 
bicarbonate buffer, pH 9.6. 
Test and control sera were diluted 1/20 in PBS (10 mM phosphate buffered saline, pH 7.4, 
containing 0.5% Tween 20 [Sigma]) and 0.5% (v/v) normal mouse serum, in polypropylene 
tubes arranged in 96-well format racks (Micronics systems, Nunc), by adding 40 µl serum to 760 
µl diluent. Each dilution of each test sample or control serum was subsequently included in 
three microtitre plates, i.e. one coated with each of the three monoclonal antibodies. Four 
replicates of each control and two replicates of each test serum were included in adjacent wells 
of each microtitre plate. 
Coated plates were emptied by flicking the contents into a sink, and blotted on paper towel. The 
wells were then filled with washing buffer (PBST) consisting of PBS containing 0.5% Tween 20 
(Sigma), and immediately emptied by flicking the contents into a sink, and blotted on paper 
towel. 
Diluted test and control sera were immediately added (100 µl per well) to the coated microtitre 
plates, and incubated with orbital shaking at 37°C for 15 min, after which plates were emptied 
and washed once as described above. Horseradish peroxidase (HRP)-conjugated homologous 
monoclonal antibody, appropriately diluted in PBST containing 1% (w/v) bovine serum albumin, 
was then added to all wells (100 µl per well). Microtitre plates which were then incubated with 
orbital shaking at 37°C for 15 min. 
Following incubation with HRP-conjugated monoclonal antibody, microtitre plates were emptied 
and washed once as described above, and immediately refilled with washing buffer in which 
wells were left to soak for 10 min. Plates were again emptied, refilled and soaked for 10 min for 
two further cycles, after which they were emptied and blotted on paper towel. A two component 
proprietary hydrogen-peroxide/3,3', 5,5' tetramethylbenzidine substrate-chromogen system 
(TMB, Kirkgard-Perry Laboratories) at 4°C was then added (100 µl per well). Substrate-
chromogen was incubated in the microtitre plates for 20 min with orbital shaking at 37°C, after 
which the reaction was quenched by the addition of 100 µl per well of 1 M orthophosphoric acid. 
Absorbances were read using a multichannel photometer (Immunoskan Plus, Labsystems) 
connected to the serial port of an IBM-compatible personal computer via an RS232C cable. 
Quality assurance and data analysis 
The quality assurance (QA) aspects of the FAO/IAEA trypanosome antigen-ELISA kit protocol 
were strictly adhered to. This protocol broadly follows the recommendations of Wright et al 
(1993). Hence, strong positive (C++), weak positive (C+), negative (C-) and conjugate controls 
(CC; serum diluent buffer without serum) were included on every plate. Results for individual 
ELISA plates were accepted or rejected based on strict QA acceptance criteria (FAO/IAEA kit 
protocol; Rebeski, personal communication). Results for test samples were expressed as 
percentage positivity (PP) values based on the median absorbance of the four replicates of the 
strong positive control serum. Acceptance of QA data was based on two levels of criteria. 
Firstly, the median absorbance of the four replicates of the strong positive control had to fall 
within a prescribed range. Secondly, the percentage positivity of three of the four absorbances 
of each of the four controls (C++, C+, C- and CC) had to fall within prescribed ranges. 
Proprietary software (Hopquik, M.C. Eisler, unpublished) was used to perform the QA 
calculations and to output the percentage positivity data for test samples as a database file for 
subsequent analysis (see below). 
Sensitivity, specificity and diagnostic efficiency calculations 
Sensitivity of the phase contrast buffy coat technique and the Ag-ELISA for each trypanosome 
species was calculated separately for each T. congolense- and T. vivax-infected animal. 
Sensitivity was calculated either including observations from day 1 following tsetse challenge, or 
including observations from day 14 following tsetse challenge. Similarly, specificity of the Ag-
ELISA for each trypanosome species was calculated separately for each non-infected control 
animal. Sensitivity was calculated as 
                                        1 
where np is the number of samples, from a total of n samples from an infected animal, with 
percentage positivity values greater or equal to the cut-off. Specificity was calculated as 
                                         2 
where nn is the number of samples, from a total of n samples from an uninfected animal, with 
percentage positivity values less than the cut-off. 
Combined estimates (CS) of sensitivity (or specificity) were obtained as weighted means for 
groups of infected or uninfected animals respectively, using the following formula: 
                              3 
where Si is the estimate of sensitivity (or specificity) for the ith of N cattle, and ni is the number 
of samples on which the sensitivity (or specificity) estimate for the ith animal is based. Finally 
95% confidence intervals for combined sensitivity (or specificity) estimates were calculated 
using the combined mean ± t × SEw where t is the value of student's t distribution at p=0.05, 
and N – 1 degrees of freedom, and SEw is the weighted standard error, calculated by: 
        4 
The diagnostic efficiencies of the Ag-ELISAs at any given percentage positivity cut-off value 
were calculated as the product of the sensitivity and specificity at that percentage positivity cut-
off value. 
The cross-reactivity of each of the three Ag-ELISAs for heterologous salivarian trypanosome 
infections was considered equivalent to the sensitivity for such infections. 
For these analyses, the Hopquik output database file (see above) was imported into Microsoft 
Access Version 2.00 (Microsoft Corporation) databases and Lotus 1-2-3 Release 5 for Windows 
(Lotus Development Corporation) spreadsheets specifically designed for this purpose. 
Results 
Phase contrast buffy coat technique 
All 40 cattle infected with T. congolense (IL 2642 [n=10], IL 1180 [n=10] or IL 2281 [n=10]) or T. 
vivax (IL Dat 1.2 [n=10]) had detectable parasitaemias during the experiments. No parasitaemia 
was detected in any of the uninfected control cattle [n=16] at any stage. After an initial pre-
patent period of infection, parasites were detected in T. congolense-infected cattle on the great 
majority of occasions of sampling. Sensitivity estimates for the phase contrast buffy coat 
technique are shown in Table 1. 
Table 1. Sensitivity estimates for the phase contrast buffy coat technique trypanosome used on 
trypanosome-infected cattle. 
  
Trypanosome  
Species 
No. of  
cattle 
No. of 
samples 
Sensitivity 
(%) 
LCL (%) UCL (%) 
Start D.† 
T. congolense 30 1224 67.0 63.4 70.6 
T. vivax 10 358 59.5 56.5 62.5 
Start D. 14‡ 
T. congolense 30 834 96.0 94.5 97.6 
T. vivax 10 228 76.3 68.7 83.9 
†Sensitivity calculated using observations from day 1 following tsetse challenge.  
‡Sensitivity calculated using observations from day 14 following tsetse challenge.  
LCL: lower 95% confidence limit.  
UCL: upper 95% confidence limit. 
The sensitivity of the phase contrast buffy coat technique, calculated using all observations from 
the first day following tsetse challenge, was at least 60% for all three of the T. 
congolense populations tested (data not shown). Individual lower 95% confidence limits (LCL 
95%) ranged from 51.5 to 66.4% and individual upper 95% confidence limits (UCL 95%) ranged 
from 71.8 to 73.6%. The overall value for sensitivity for T. congolense infections was 67.0% 
(95% confidence intervals [C.I.] 63.4 to 70.6%). The corresponding sensitivity for the one T. 
vivax population tested was 59.5% (95% C.I. 56.5 to 62.5%). 
The corresponding sensitivity calculated using only observations made from the 14th day 
following tsetse challenge was at least 95% for all three of the T. congolense populations tested 
(data not shown). Individual lower 95% confidence limits (LCL 95%) ranged from 92.7 to 93.5% 
and individual upper 95% confidence limits (UCL 95%) ranged from 98.2 to 99.7%. The overall 
value for sensitivity for T. congolense infections was 96.0% (95% C.I. 94.5 to 97.6%). The 
corresponding sensitivity for the one T. vivax population tested was 76.3% (95% C.I. 68.7 to 
83.9%). 
Ag-ELISA 
Sensitivity estimates and their 95% confidence intervals (C.I.) for the three antigen-ELISAs are 
presented in Tables 2 to 4. 
Sensitivity of the T. congolense Ag-ELISA 
Sensitivity estimates for the T. congolense Ag-ELISA are presented in Table 2. Its overall 
sensitivity (based on a 5% positivity cut-off, and including results for all samples collected from 
day 1 following tsetse challenge) for all T. congolense-infected cattle (n=30) was 10.5% (95% 
C.I. 4.3 to 16.7%). Restricting the analysis (based on a 5% positivity cut-off) to those samples 
collected from day 14 following tsetse challenge did not appreciably affect the overall sensitivity 
estimate, which became 12.4% (95% C.I. 5.4 to 19.5%). 
On lowering the cut-off to 2.5% positivity, the sensitivity (including results for all samples 
collected from day 1 following tsetse challenge) increased to 25.1% (95% C.I. 18 to 32.2%). On 
raising the cut-off to 10% positivity, the sensitivity (including results for all samples collected 
from day 1 following tsetse challenge) decreased to 4.0% (95% C.I. 1.1 to 6.8%). 
Table 2. Sensitivity estimates for the T. congolense ELISA. 
Analysis 
from day† 
Cut off 
(PP) (%) 
Trypanosome 
Species 
No. of 
cattle 
No. of 
samples 
Sensitivity 
(%) 
LCL (%) UCL (%) 
1  
   
   
   
  
  
  2.5 
T. congolense 30 1162 25.1 18.0 32.2 
T. vivax 10 283 39.2 28.6 49.8 
  5 
T. congolense 30 1162 10.5 4.3 16.7 
T. vivax 10 283 22.3 10.9 33.6 
10 
T. congolense 30 1162 4.0 1.1 6.8 
T. vivax 10 283 14.8 5.4 24.3 
14  
   
   
   
  
  
2.5 
T. congolense 30 773 26.8 18.6 34.9 
T. vivax 10 153 51.6 39.0 64.3 
5 
T. congolense 30 773 12.4 5.4 19.5 
T. vivax 10 153 37.9 22.2 53.7 
10 
T. congolense 30 773 5.7 1.5 9.9 
T. vivax 10 153 26.1 11.4 40.8 
†Analysis including samples from day 1 or from day 14 following tsetse challenge.  
PP: Percentage positivity.  
LCL: lower 95% confidence limit.  
UCL: upper 95% confidence limit 
Cross-reactivity of T. congolense-infected cattle in the T. brucei Ag-ELISA 
The cross-reactivity (i.e. sensitivity) of the T. brucei Ag-ELISA (based on a 5% positivity cut-off, 
and including results for all samples collected from day 1 following tsetse challenge) for T. 
congolense-infected cattle (n=30) was 9.0% (95% C.I. 5.3% to 12.6%), (see Table 3). 
Restricting the analysis (based on a 5% positivity cut-off) to those samples collected from day 
14 following tsetse challenge slightly increased the overall sensitivity estimate to 14.2% (95% 
C.I. 8.6 to 19.8%) (see Table 3). 
Table 3. Sensitivity estimates for the T. brucei ELISA. 
Analysis 
from 
day† 
Cut off 
(PP)  
(%) 
Trypanosome 
Species 
No. of 
cattle 
No. of  
samples 
Sensitivity  
(%) 
LCL  
(%) 
UCL  
(%) 
1  
   
   
   
  
  
  2.5 
T. congolense 30 1159 28.5 24.0 33.0 
T. vivax 10 283 23.0 16.9 29.0 
  5 
T. congolense 30 1159 9.0 5.3 12.6 
T. vivax 10 283 5.3 0.6 10.0 
10 
T. congolense 30 1159 2.9 0.7 5.1 
T. vivax 10 283 1.4 0.0 3.1 
14  
   
   
   
  
  
2.5 
T. congolense 30 669 44.5 38.2 50.9 
T. vivax 10 153 32.0 22.2 41.9 
5 
T. congolense 30 669 14.2 8.6 19.8 
T. vivax 10 153 9.2 1.4 16.9 
10 
T. congolense 30 669 4.6 1.3 8.0 
T. vivax 10 153 2.6 0.0 0.0 
†Analysis including samples from day 1 or from day 14 following tsetse challenge.  
PP: Percentage positivity.  
LCL: lower 95% confidence limit.  
UCL: upper 95% confidence limit. 
Cross-reactivity of T. congolense-infected cattle in the T. vivax Ag-ELISA  
The cross-reactivity (i.e. sensitivity) of the T. vivax Ag-ELISA (based on a 5% positivity cut-off 
and including results for all samples collected from day 1 following tsetse challenge) for all T. 
congolense-infected cattle (n=30) was 15.0% (95% C.I. 11.1 to 19.0%), (see Table 4). 
Restricting the sensitivity data to those samples collected from day 14 following tsetse challenge 
had little effect on the sensitivity estimate, which became 13.3% (95% C.I. 9.3 to 17.3%) (Table 
4). 
Table 4. Sensitivity estimates for the T. vivax ELISA. 
Analysis 
from day† 
Cut off 
(PP) (%) 
Trypanosome 
Species 
No. of 
cattle 
No. of  
samples 
Sensitivity  
(%) 
LCL  
(%) 
UCL  
(%) 
1  
   
   
   
  
  
  2.5 
T. congolense 30 1163 35.1 30.1 40.0 
T. vivax 10 283 35.3 23.5 47.2 
  5 
T. congolense 30 1163 15.0 11.1 19.0 
T. vivax 10 283 24.4 10.5 38.3 
10 
T. congolense 30 1163 5.3 2.3 8.4 
T. vivax 10 283 14.5 4.0 25.0 
14  
   
   
   
  
  
2.5 
T. congolense 30 773 32.2 26.3 38.1 
T. vivax 10 153 41.8 26.5 57.2 
5 
T. congolense 30 773 13.3 9.3 17.3 
T. vivax 10 153 32.7 15.0 50.4 
10 
T. congolense 30 773 4.3 1.5 7.0 
T. vivax 10 153 19.6 4.4 34.8 
†Analysis including samples from day 1 or from day 14 following tsetse challenge.  
PP: Percentage positivity.  
LCL: lower 95% confidence limit.  
UCL: upper 95% confidence limit. 
Sensitivity of the T. vivax Ag-ELISA 
Sensitivity estimates for the T. vivax Ag-ELISA are presented in Table 4. The overall sensitivity 
(based on a 5% positivity cut-off, and including results for all samples collected from day 1 
following tsetse challenge) for T. vivax-infected cattle (n=10) was 24.4% (95% C.I. 10.5 to 
38.3%). Restricting the analysis (based on a 5% positivity cut-off) for T. vivax-infected cattle to 
those samples collected from day 14 following tsetse challenge moderately increased the 
overall sensitivity estimate to 32.7% (95% C.I. 15.0 to 50.4%). 
On lowering the cut-off to 2.5% positivity, the overall sensitivity for T. vivax-infected cattle, 
including results for all samples collected from day 1 following tsetse challenge, was 35.3% 
(95% C.I. 23.5 to 47.2%). On raising the cut-off to 10% positivity, the overall sensitivity for T. 
vivax-infected cattle, including results for all samples collected from day 1 following tsetse 
challenge, was 14.5% (95% C.I. 4.0 to 25.0%). 
Cross-reactivity of T. vivax-infected cattle in the T. brucei Ag-ELISA 
The cross-reactivity (i.e. sensitivity) of the T. brucei Ag-ELISA (based on a 5% positivity cut-off, 
and including results for all samples collected from day 1 following tsetse challenge) for T. 
vivax-infected cattle (n=10) was 5.3% (95% C.I. 0.6 to 10.0%) (Table 3). Restricting the analysis 
(based on a 5% positivity cut-off) for T. vivax IL Dat 1.2-infected cattle to those samples 
collected from day 14 following tsetse challenge moderately increased the overall sensitivity 
estimate to 9.2% (95% C.I. 1.4 to 16.9%) (Table 3). 
Cross-reactivity of T. vivax-infected cattle in the T. congolense Ag-ELISA 
The cross-reactivity (i.e. sensitivity) of the T. congolense Ag-ELISA (based on a 5% positivity 
cut-off, and including results for all samples collected from day 1 following tsetse challenge) 
for T. vivax IL Dat 1.2-infected cattle (n=10) was 22.3% (95% C.I. 10.9 to 33.6%) (Table 2). 
Restricting the analysis (based on a 5% positivity cut-off) for T. vivax IL Dat 1.2-infected cattle to 
those samples collected from day 14 following tsetse challenge moderately increased the 
overall sensitivity estimate to 37.9% (95% C.I. 22.2 to 53.7%, Table 2). 
Specificity of the trypanosome Ag-ELISAs 
The specificity of the trypanosome antigen-ELISAs based on the results for uninfected control 
cattle (n=16) are presented in Table 5. 
Specificity of the T. brucei Ag-ELISA 
The overall specificity (based on a 5% positivity cut-off) of the T. brucei Ag-ELISA for uninfected 
cattle (n=16) was 94.2% (95% C.I. 90.5 to 97.8%). On lowering the cut-off to 2.5% positivity, the 
overall specificity of the T. brucei Ag-ELISA for uninfected cattle, was 75.8% (95% C.I. 71.4 to 
80.3%). On raising the cut-off to 10% positivity, the overall specificity of the T. brucei Ag-ELISA 
for uninfected cattle was 98.3% (95% C.I. 96.0 to 100.0%). 
Specificity of the T. congolense Ag-ELISA 
The overall specificity (based on a 5% positivity cut-off) of the T. congolense Ag-ELISA for 
uninfected cattle (n=16) was 94.9% (95% C.I. 90.8 to 99.1%). On lowering the cut-off to 2.5% 
positivity, the overall specificity of the T. congolense Ag-ELISA for uninfected cattle, was 85.4% 
(95 C.I. 78.9% to 91.0%). On raising the cut-off to 10% positivity, the overall specificity of the T. 
congolense Ag-ELISA for uninfected cattle was 98.3% (95% C.I. 95.6 to 100.0%). 
Table 5. Specificity estimates for the trypanosome Ag-ELISAs.   
Cut off (PP)  
(%) 
ELISA nominal 
specificity 
No. of  
cattle 
No. of  
samples 
Specificity  
(%) 
LCL  
(%) 
UCL  
(%) 
  2.5 T. brucei 16 530 75.8 71.4 80.3 
  5 T. brucei 16 631 94.2 90.5 97.8 
10 T. brucei 16 636 98.3 96.0 100.0 
  2.5 T. congolense 16 530 85.4 79.8 91.0 
  5 T. congolense 16 631 94.9 90.8 99.1 
10 T. congolense 16 636 98.3 95.6 100.0 
  2.5 T. vivax  16 530 62.6 50.4 74.7 
  5 T. vivax  16 631 78.9 66.6 91.3 
10 T. vivax  16 636 92.3 83.7 100.0 
P: Percentage positivity.  
LCL: lower 95% confidence limit.  
UCL: upper 95% confidence limit. 
Specificity of the T. vivax Ag-ELISA 
The overall specificity (based on a 5% positivity cut-off) of the T. vivax Ag-ELISA for uninfected 
cattle (n=16) was 78.9% (95% C.I. 66.6 to 91.3%). On lowering the cut-off to 2.5% positivity, the 
overall specificity of the T. vivax Ag-ELISA for uninfected cattle, was 62.6% (95% C.I. 50.4 to 
74.7%). On raising the cut-off to 10% positivity, the overall specificity of the T. vivax Ag-ELISA 
for uninfected cattle was 92.3% (95% C.I. 83.7 to 100.0%). 
Relationship between cut-off value, sensitivity, specificity and diagnostic efficiencies of 
the T. congolense and T. vivax Ag-ELISAs 
The relationships between cut-off value, sensitivity, specificity and diagnostic efficiency of the T. 
congolense and T. vivax Ag-ELISAs are shown in Figures 1 and 2. 
Discussion 
The sensitivity and specificity of the FAO/IAEA trypanosome antigen detection ELISAs have 
been formally investigated using sera from defined laboratory infections of cattle in a double-
blind trial. Three unrelated cloned populations of T. congolense originating from different areas 
of sub-Saharan Africa and a single cloned population of T. vivax were used for these studies. 
The phase contrast buffy coat technique (Murray et al 1977) was used as a reference method 
for parasitological diagnosis. These investigations showed that although the Ag-ELISAs had 
good diagnostic specificity for trypanosome infections, trypanosome species specificity was 
poor, and diagnostic sensitivity and hence overall diagnostic efficiency were unsatisfactory. 
 
Figure 1.  Sensitivity, specificity and efficiency of the T.congolense Ag-ELISA in relation to cut-
off. Analyses include samples from day 14 following tsetse challenge. 
The sensitivity of the phase contrast buffy coat technique for T. congolense infections was 
reasonably high (67.0%), when results for all samples collected from day 1 following tsetse 
challenge were included in the analysis. When only those samples collected 14 days or more 
after tsetse challenge were included, the diagnostic sensitivity for this trypanosome species was 
very high (96.0%). These studies were conducted on experimentally infected cattle in excellent 
animal handling facilities in close proximity to a well-equipped laboratory. The sensitivity 
estimates obtained here for the phase contrast buffy coat technique therefore may not reflect 
the situation under field conditions. The sensitivity of this technique for T. vivax infections was 
lower, but nevertheless reasonably high (76.3%) when only those samples collected 14 days or 
more after tsetse challenge were included. 
 
Figure 2. Sensitivity, specificity and efficiency of the T.vivax Ag-ELISA in relation to cut-off. 
Analyses include samples from day 14 following tsetse challenges. 
In contrast to the phase contrast buffy coat technique, the sensitivities of the T. 
congolense and T. vivax Ag-ELISAs for infections with homologous species parasites were very 
low, at the recommended cut-off value of 10% positivity. This was regardless of whether or not 
the results for samples taken during the first 14 days following tsetse challenge were included 
(see Tables 2–4). Lowering the cut-off percentage positivity improved the sensitivity estimates, 
as shown in Figures 1 and 2, but only at the expense of specificity. The optimal diagnostic 
efficiency for the T. congolenseELISA occurred at a cut-off of approximately 1% positivity, at 
which both sensitivity and specificity were approximately 60%. For the T. vivax ELISA there was 
no value for the cut-off at which both sensitivity and specificity were above 50%. In fact, the best 
possible diagnostic efficiency for this trypanosome species, which occurred when the cut-off 
was in the range of approximately 2–5% positivity was scarcely better than 25% (the value that 
would be expected from tossing an unbiased coin). Since no T. brucei-infected cattle were 
investigated, it was not possible to assess the sensitivity or diagnostic efficiency of the T. 
brucei ELISA in these studies. 
In addition to poor sensitivity, the results obtained here suggest that the species specificity of 
these ELISAs for salivarian trypanosome infections is also poor, at least for T. 
congolense and T. vivaxinfections. 
In summary, the diagnostic sensitivities of the current FAO/IAEA Ag-ELISAs for T. 
congolense and T. vivax are inadequate for these tests to be useful in sero-epidemiological 
investigations of bovine trypanosomosis. In contrast, it was shown that at least under optimised 
conditions, good diagnostic sensitivity is possible using the phase contrast buffy coat technique. 
Despite the poor sensitivity results for the Ag-ELISAs, and the excellent sensitivity results for the 
phase contrast buffy coat technique obtained here, the development of a serological diagnostic 
method for bovine trypanosomosis remains a worthwhile objective. Improvement in sensitivity is 
not the only reason why a serological diagnostic for trypanosomosis would be a desirable 
addition to parasitological techniques. Indirect diagnostic methods, such as serological 
methods, offer many potential advantages over direct methods. Examples are testing under 
controlled laboratory conditions, non-subjectivity of testing, provision of quality assurance, and 
the possibility of repeat testing of samples stored under optimised conditions. Enzyme-linked 
immunosorbent assay (ELISA)-based serological methods offer further advantages of high 
sample throughput suitable for large-scale epidemiological investigations, and automated 
processing and analysis of the large body of resultant data using widely available 
microcomputer technology. 
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Summary 
The efficacy of a tsetse-control programme can be measured through tsetse-density monitoring 
on the one hand and through infection rate and packed cell volume (PCV) monitoring in cattle 
on the other hand. The objective of this study was to determine the suitability of the antigen-
ELISA (Ag-ELISA) as an additional method for assessing the efficacy of a tsetse-control 
programme based on the use of traps and screens impregnated with deltamethrine. The buffy 
coat test was used as a reference to evaluate the available Ag-ELISA (using two kits: one from 
the International Livestock Research Institute (ILRI) and another from the International Atomic 
Energy Agency (IAEA)). Herd monitoring was carried out in 8 localities: 4 in the test area and 4 
in an untreated area, and the results were compared over 12 months. The apparent tsetse 
density in the treated area was reduced by nearly 95% after one month of control, and few flies 
were caught thereafter. A similar trend was observed for rates of infection in cattle which were 
reduced from 6 to 2% in the treated area but increased from 3 to 10% in the untreated control 
area. At the beginning of the experiment, mean PCV was the same (29.4%) for cattle in both 
treated and untreated areas. After 12 months of operation, the mean PCV in the treated area 
was higher than that in the untreated area. Positive antigen prevalence did not correlate with 
trypanosomal infection rate in cattle, nor with apparent tsetse density. The two Ag-ELISAs 
suffered from low sensitivity as measured on a parasite positive population for 
both Trypanosoma congolense and T. vivax and the Ag-ELISA should not be recommended for 
trypanosomosis monitoring on its own. 
Introduction 
There is a move in Mali towards tsetse and trypanosomosis control using insecticide-
impregnated traps and screens. There is a need for an improved trypanosomosis diagnosis for 
monitoring such control operations, as the currently available tests have limited sensitivity. The 
antigen-ELISA is a candidate test. In 1988 ILRAD proposed an Ag-ELISA for trypanosomosis 
diagnosis based on monoclonal antibodies specific for the three main species of cattle 
trypanosomosis (T. vivax, T. congolense and T. brucei) (Nantulya 1990; Nantulya and Lindqvist 
1989; Masake and Nantulya 1991). The test was validated in ten African laboratories. The 
different results (Diall et al 1993) called for refinements of the test by IAEA. 
The aim of the present study was twofold: 
1. Evaluation of the Ag-ELISA as a tool for assessing the impact of tsetse control 
programmes on the incidence of trypanosomal infections in livestock. 
2. Evaluation of the sensitivity and the specificity of the Ag-ELISA, and comparison of 
ILRI's and IAEA's kits. 
Materials and methods 
The sector of Niena in Mali was chosen for the pilot tsetse-control programme. It covers 500 
km2 with 56,000 cattle. Two species of flies are prevalent: (Glossina palpalis gambiensis, G. 
tachinoides)alongside the River Bagoé and its affluents. The annual rain fall is 800–1000 mm. 
Tsetse monitoring 
Impregnated traps were deployed alongside the River Bagoé and its tributaries within the limits 
of the control area. Entomological surveys were carried out every 1–2 months using biconical 
traps to monitor the apparent density of tsetse flies at selected points on the river banks. For 
comparison purposes the same studies were conducted at other sites selected in a 
neighbouring untreated area. 
Cattle infection monitoring and packed cell volume 
Fifty animals were selected in each of eight villages. Four of the villages were located in the test 
area, while the four others were located in the non-treated (control) area. These animals were 
ear-tagged and bled every two months for parasite and antigen monitoring. The parasite 
monitoring was done using the buffy coat technique (BCT). Sera were collected and stored at -
20°C for antigen-detection. 
Mean packed red cell volume was compared at the beginning of the experiment and 12 months 
later. One hundred sera from trypanosome-negative (using BCT) animals with low packed cell 
volume (PCV) (PCV ≥ 25%) and 100 sera from trypanosome-negative (using BCT) animals with 
normal PCV (PCV ≥ 25%) were tested by Ag-ELISA in order to determine if there were 
significantly more antigen-positive cases in the low PCV group than in the normal PCV group 
for T. congolense and T. vivax. 
Data analysis 
To determine the effect of the tsetse control on trypanosomal prevalence in cattle, the results 
obtained in the treated area were first compared over different sampling periods and then with 
those in the control area over the same periods. Correlations were also made between tsetse fly 
density and trypanosomosis prevalence in both treated and control areas on one hand and with 
antigen positivity on the other hand. 
Results 
Entomolosgy 
Before the beginning of tsetse control, the apparent tsetse densities were relatively high for both 
tsetse species and in both treated and untreated areas. One month after the beginning of the 
control, the reduction in apparent density was 93% for G. p. gambiensis and 98% for G. 
tachinoides (Figure 1). One year after the deployment of the targets hardly any flies were 
captured in the treated area. Apparent tsetse densities of G. p. gambiensis were 11.6 and 16.7 
in untreated and treated areas, respectively, in March 1993, one month before the start of tsetse 
control, and 3.25 and 0, respectively, 13 months later in April 1994. Corresponding apparent 
densities for G. tachinoides were 2.4 and 3.7, before tsetse control, and 1.90 and 0, 
respectively, 12 months after tsetse control. 
Cattle infections and PCV 
At the beginning of the project the prevalence of trypanosomal infections in cattle in the selected 
herds was 6.2% in the treated area and 3.4% in the untreated area. It should be noted, 
however, that before the study animals were being regularly treated by the owners using either 
Berenil® or Trypamidium®, and this may account for the low trypanosomal infection rates in the 
cattle at the beginning of the experiment. Once the study started, however, animals were not 
treated independently by the owners and the detection of the parasite was the only indication for 
treatment. During the study, fluctuations were observed in infection rates in both areas. 
 
Figure 1.  Variations of the densities in the treated and untreated areas. 
One year after the beginning of the study, the prevalence of trypanosomal infections in the 
treated area was lower (2%) than in the untreated area (9%) (Table 1). 
With regard to the PCV, the results of the antigen-detection ELISA tests using both kits are 
shown in Table 2 for samples from cattle with normal PCVs (≥ 25%) and low PCVs (<25%). 
Table 1. Summary of parasitological and haematological results in eight villages. 
Area Village 
Start March 
93 Prev† PCV 
+1 month 
May 93 
Prev Pcv 
+3 months 
July  93 
Prev Pcv  
+8 months 
Nov. 93  
Prev Pcv  
+11 
months 
Feb. 94   
Prev Pcv 
+12 
months 
April 94 
Prev Pcv 
Test  
   
  
  
1 3.6 31.7 0.0 29.5 0.0 45.7 0.0 45.7 6.8 35.7 0.0 32.4 
2 8.0 29.8 14.0 28.8 2.0 32.0 13.0 32.1 6.7 31.0 4.8 28.4 
3 6.0 28.6 10.0 31.5 4.0 34.0 2.1 34.0 2.4 33.8 0.0 33.2 
4 7.9 27.2 2.0 29.7 0.0 30.7 0.0 35.4 0.0 31.9 3.0 31.8 
Mean 6.2 29.4 6.5 29.9 1.5 33.1 3.7 36.8 4.2 33.2 2.0 31.3 
Control  
   
  
  
5 1.0 30.6 16.0 29.8 0.0 31.9 26.3 30.6 21.6 30.1 14.3 27.9 
6 2.0 26.9 4.0 32.1 0.0 31.9 0.0 33.0 2.8 32.3 6.2 25.7 
7 4.0 32.0 14.0 31.2 12.5 32.4 4.3 33.5 0.0 33.8 2.8 26.7 
8 5.9 27.9 18.0 24.9 13.5 29.7 16.7 29.2 2.6 28.9 13.2 26.2 
Mean 3.5 29.4 13.0 29.5 6.2 31.6 10.8 31.6 6.7 31.3 9.0 26.6 
†Prev: trypanosomal prevalence 
Table 2. Results of the antigen-detection ELISA test using IAEA and ILRI kits. 
PCV 
No. of 
sera 
Species  
No. 
positive 
(IAEA) 
No. positive   
(ILRI) 
Normal (>25%) 
  
100 
  
T. brucei 7 12 
T. congolense 5 15 
T. vivax 10 9 
Low (<25%) 
  
100 
  
T. brucei 24 42 
T. congolense 10 8 
T. vivax 10 8 
2 analysis was performed to determine if the observed differences in numbers detected positive 
between normal and low PCV samples were statistically significant (Table 3). 
Table 3. 2 values for comparing numbers detected positive between normal and low PCV 
samples.   
  
ILRI IAEA  
 2 P value  2 P value 
T. congolense    1.77  0.18 1.15 0.28 
T. vivax     0 0 0.06 0.81 
T. brucei  21.33  <0.001 9.77 <0.01 
Table 4. Results of the antigen-ELISA test for BCT positive sera using AIEA and ILRI kits.  
Positive by BCT Monoclonal 
IAEA ILRI 
No. of 
sera 
No. positive by  
Ag-ELISA 
No. of 
sera 
No. positive by 
Ag-ELISA 
T. congolense T. brucei 80 7 (9) † 80 0 (0) 
 
T. congolense 
 
37 (46) 
 
65 (81) 
 
T. vivax 
 
11 (14)  
 
2 (2.5) 
T. vivax T. brucei 60 1 (2)  50 1 (2) 
 
T. congolense 
 
13 (22) 
 
20 (40) 
 
T. vivax 
 
15 (25) 
 
17 (34) 
†Percentage in parentheses. 
The results indicated that only for T. brucei was the difference statistically significant for both 
kits. 
Correlation between parasitological and haematological results 
Monthly parasitological and haematological parameters were recorded. The data (Figures 2A 
and 2B) demonstrate no correlation between antigen and parasitaemia results in either area. 
PCVs in animals treated and untreated areas were similar until month 11 but were lower in 
animals in untreated areas in month 12. 
Evaluation of sensitivity and specificity 
Of 1201 samples collected and tested using the BCT, 80 were positive to T. congolense and 50 
to T. vivax. Using ILRI's and IAEA's reagents, these sera were further examined and the 
sensitivities and specificities, and the positive and negative predictive values (using the three 
monoclonals for each kit) were calculated and compared to BCT results. The c2 test was used 
to compare the performance of the ILRI and IAEA tests. The specificity of the Ag-ELISA was 
also determined on 596 sera collected from a trypanosome-free zone in Nara in Mali, but using 
only IAEA reagents. 
The results of the evaluations are shown in Table 4 for IAEA and ILRI reagents, respectively. 
Ag-ELISA test statistics on samples positive to T. congolense by BCT are shown in Table 5. 
The performance of both sets of reagents was poor when using monoclonal T. brucei and 
monoclonal T. vivax. The results given in Table 5 when monoclonal T. congolense was used 
show that ILRI's reagents detected more positive cases than did IAEA's reagents. 
 Figure 2A. Validations of the mean PCV, infection rates using the Ag-ELISA and BCT in treated 
areas. 
Figure 2B.  Validations of the mean PCV, infection rates using the Ag-ELISA and BCT in 
untreated areas. 
Table 5.  ELISA test results on samples positive to T. congolense by buffy coat technique.   
Parameters T. brucei 
T. 
congolense  
T. vivax 
ILRI  IAEA ILRI IAEA  ILRI  IAEA 
Sensitivity (%) 0  9  81  46  2.5  14  
Specificity (%) 100  100  100  100  100  100  
Positive predictive value (%) 0  77  100  100  100  100  
Negative predictive value (%) 92  93  98.4 92  92  92  
Table 6. Overall ELISA test performance compared to BCT (positive to T. congolense).   
Parameters ILRI IAEA 
Sensitivity (%)  81  46  
Specificity (%) 99.8 98.1 
Positive predictive value (%) 97 67 
Negative predictive value (%) 98.4 96 
Table 7. ELISA test results on samples (positive to T. vivax) by BCT.   
Parameters  
T. brucei T. congolense T. vivax 
ILRI  IAEA  ILRI IAEA  ILRI  IAEA 
Sensitivity (%)  2  2 40 22  34  25 
Specificity (%) 100 100 100 100 100 100 
Positive predictive value (%) 100 100 100 100 100 100 
Negative predictive value (%) 95  94 97 95 97 96 
Table 6 gives the results of the overall comparison of the ELISA test to BCT (positive to T. 
congolense) assuming that sera positive to T. brucei and T. vivax monoclonals were false 
positives. The overall results showed that the ILRI reagents were more sensitive and had higher 
predictive values than the IAEA reagents. 
ELISA test results on samples positive for T. vivax by BCT are shown in Table 7. The results 
showed very low sensitivities for both reagents for the T. brucei monoclonal. The results 
using T. congolense or T. vivax monoclonal again indicate low sensitivity of the test for both 
reagents. 
Table 8 gives the results of the comparison of the ELISA test to BCT (positive to T. vivax) 
assuming that sera positive to T. brucei and T. congolense monoclonals are false positive. The 
overall results showed that ILRI's reagents are slightly more sensitive. 
2 squared analysis was used to compare the performance of ILRI and IAEA kits, which detected 
65/80 and 37/80 samples, respectively, positive to T. congolense of those detected positive 
to T. congolense by BCT, and 17/50 and 15/60 samples, respectively, positive to T. vivax of 
those detected positive to T. vivax by BCTs. The calculated value of 2 2= 19.72 (P<0.001) 
demonstrated a large difference in performance of the two kits for BCT-detected T. 
congolense infections. The ILRI kit was more sensitive than the IAEA kit. However, there was 
no difference in performance of the two  kits in relation to T. vivax (2 = 0.68). 
Table 8. ELISA test performance compared to BCT (positive to T. vivax).   
Parameters ILRI’s reagents  IAEA’s reagents 
Sensitivity (%) 34 25 
Specificity (%) 97.8  98.5 
Positive predictive value (%) 45 52 
Negative predictive value (%) 97 96 
Table 9. Results of the evaluation of the specificity of Ag-ELISA from samples collected in a 
trypanosome-free zone. 
Trypanosome species Cut-off point (%)  Specificity 
T. brucei 5 96.1 
  10 98.2 
  15  99.2 
  20 99.3 
T. congolense  5 99.8 
  10–20 100 
T. vivax 5 98.2 
  10 99.3 
  15–20 99.5 
Specificity of the antigen-detection ELISA 
The specificity of the ELISA was evaluated in Seibersdorf (Austria) (D. Rebeski, personal 
communication) based on test results for 596 sera from Nara (Table 9). 
High specificity was obtained with a cut-off point of 10% for all three species. 
Discussion and conclusions 
The estimation of the sensitivity and the specificity of a test requires two types of populations: 
one completely disease free, and one in which every animal is infected (Burges 1988). To fulfill 
these conditions in the present study the sera were collected from two different parts of the 
country: the first a trypanosome-free zone (Nara) and the second a trypanosome-infected area 
(Niena). One thousand, two hundred and one sera collected in Nara were used to estimate the 
sensitivity of the test and 596 sera from Niena were tested for the specificity of the assay. 
Ease of application, cost and reliability are some of the important factors in the choice of a test. 
Other important factors are: which test is most sensitive, which test is most specific, are the 
tests independent? These criteria are important since tests that are high in sensitivity and/or 
specificity are ideally required (Burges 1988). The Ag-ELISA was evaluated using two sets of 
reagents: ILRI's and that of IAEA. 
The following conclusions were made: 
1. The specificity when measured on a negative population from a tsetse-free area was 
satisfactory for each trypanosomal species: 98–99% at a cut-off point of 10%. 
2. Both kits (ILRI and IAEA ) suffered from low sensitivity when measured on parasite-
positive populations for both T. congolense (respectively 81 and 46%) and T. 
vivax (respectively 34 and 25%). 
3. There were significantly more antigen-positive cases (using the monoclonal T. brucei) in 
a low PCV population than in a normal PCV population for T. congolense. 
In conclusion, the use of antigen-ELISA is not recommended for trypanosome monitoring due to 
its low sensitivity. Further, the prevalence of antigen-positive samples was found to be 
uncorrelated with the trypanosomal infection rate in cattle as determined by BCT. 
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Summary 
The early history of trypanosomosis in cattle in KwaZulu-Natal, South Africa, dates back to the 
latter part of the previous century, when it caused serious epidemics in northern KwaZulu. The 
advent of organo-chlorine insecticides provided suitable means to remove tsetse, and between 
1945 and 1952 G. pallidipes was eradicated from northern KwaZulu-Natal by large-scale aerial 
spraying operations. Since 1954 only occasional and isolated cases of trypanosomosis have 
been reported. However, in 1990 bovine trypanosomosis re-emerged in this area. Using thick 
and thin blood smears, 10-15% of these animals in three districts, Ingwavuma, Ubombo and 
Hlabisa, were found to be infected with either T. congolense and/or T. vivax. By the end of 1993 
more than 115,000 cattle were treated, costing nearly US$ 115,000, in treatment alone. 
Subsequently a more detailed survey was launched using the antigen detection ELISA to 
estimate the extent of the problem in the area. 
Each of the four districts at risk (Nongoma, Ingwavuma, Ubombo and Hlabisa) was divided into 
sections (n=137) with one or more assigned to a diptank (n=106). Twenty cattle, selected 
systematically as they went through the diptank, were sampled (serum, haematocrit for packed 
cell volume (PCV) and buffy coat smears) per section. A total of 3166 samples were collected. 
Buffy coat smear examination revealed a Trypanosoma prevalence of between 2.4–9.8%. The 
Ag-ELISA results also showed a high prevalence of T. brucei. However, comparison of results 
of smear examination with Ag-ELISA showed overall rates of infection by the Ag-ELISA to be 
much higher, and these did not appear to reflect the clinical situation. It was therefore concluded 
that the cut-off optical density (OD) value of 0.05 for positive cases was not very sensitive and 
alternative criteria to determine positive cases must be found. Presently the Ag-ELISA cannot 
be used as a definitive tool to guide intervention studies in KwaZulu-Natal. 
Introduction 
The early history of trypanosomosis in cattle in KwaZulu-Natal dates back to the previous 
century, when the then governor of Natal asked Sir David Bruce to investigate the notorious 
'tsetse-fly disease' (=nakane, a Zulu word which has developed into the colloquial name 
nagana) in northern KwaZulu-Natal (then Zululand). He found both T. brucei and T. 
congolense in domestic animals in Zululand, the latter being responsible for the vast majority of 
cases of nagana in cattle while no less than 24% of the game animals examined harboured 
trypanosomes (Bruce 1895, 1897). Curson (1924, cited by Henning 1956) also found another 
pathogenic trypanosome, T. vivax, in domestic animals in Zululand. Bruce (1895) was the first to 
prove that nagana was spread by tsetse-flyGlossina spp and Jowett (1911) demonstrated that 
pathogenic trypanosomes can also be transmitted mechanically by other biting 
flies. Glossina spp was wide-spread in the western and eastern Transvaal (G. m. 
morsitans) and north-eastern KwaZulu-Natal (G. pallidipes, G. austeni and G. brevipalpis) in the 
early 1800's (Henning 1956). They disappeared from large parts of these areas with the 
rinderpest pandemic of 1896–1897. 
Soon after the annexation of Natal by the British in 1887 game protection laws were enforced, 
as a result of which the indigenous antelopes multiplied rapidly. Parts previously devoid of game 
(due to excessive hunting) now swarmed with antelopes of all species. With this increase and 
extension of game, tsetse-fly and nagana spread. By 1894 the disease assumed such alarming 
proportions that its investigation was undertaken by Bruce (Bruce 1895). The rinderpest 
pandemic destroyed almost entire populations of wild animals. However, in parts of Zululand, 
including the present-day game reserves, pockets of wild animals and tsetse flies survived and 
by 1905 nagana was once again threatening livestock. Glossina pallidipes dispersed into 
farming areas causing serious epidemics (Henning 1956). The advent of organochlorine 
insecticides provided suitable means to remove tsetse flies, and between 1945 and 1952 G. 
pallidipes was eradicated from Zululand by large-scale aerial spraying operations (Henning 
1956). From 1952–1987 only isolated cases of nagana were reported from Zululand. Most of the 
cases occurred around the St Lucia lake system where G. austeniand G. brevipalpis still 
occurred. At that time it was assumed that since both these Glossina spp favour dense, woody 
coverts, riverine thickets, or forests often associated with high rainfall or subsoil moisture, their 
distribution would be much more confined (than savanna tsetse flies) and will therefore never 
become a serious economic problem (Henning 1956). However, human and animal populations 
have steadily increased, resulting in closer contact between cattle and the shaded thicket and 
riverine habitats of the fly and in 1990 bovine trypanosomosis re-emerged in this area (Bosman 
1990). 
During 1990 an increase in 'redwater' was reported by the local community in areas surrounding 
the game reserves. On further investigation nagana was diagnosed at a diptank east of the 
Hluhluwe Game Reserve. A survey was started using thick and thin blood smears from 20 
emaciated cattle selected at diptanks in the area. This survey revealed that 5–15% of cattle in 
three districts (Ingwavuma, Ubombo and Hlabisa) were infected with either T. 
congolense and/or T. vivax (Figure 1). As soon as a positive diagnosis was made the whole 
diptank area was considered infected. The dip compound at the diptank was changed from 
amitraz (Triatix) to cyhalothrin (Grenade) and animals reported sick by the owner were treated, 
at first with diminazene (Berenil) and later with homidium bromide (Ethidium). Later blanket 
treatment with homidium bromide was applied. By the end of 1993 more than 115,000 cattle 
had been treated, costing nearly US$ 115,000 in treatment alone. The costs increase 
substantially when other costs like drug administration (equipment, travel, personnel, time, etc), 
change in dipping compound, etc, are added. Accurate data on production losses and actual 
mortality are not available but nagana was a major cause of death of animals which were 
already under severe stress caused by the drought conditions which prevailed in the area at that 
time. The treatments and change in dipping compound were very effective in rapidly reducing 
clinical cases. However, pyrethroid resistance developed in ticks and from April 1993 the 
diptanks reverted back to amitraz and every fifth animal was also treated with deltamethrin 
(Deca-spot) in order to maintain some level of fly control. 
 Figure 1.  Prevalence of nagana in KwaZulu-Natal as determined by Ag-ELISA and BCT. 
The nagana problem seems to be confined to some 16,000 km2 of northern KwaZulu-Natal 
comprising 426,000 people, 300,000 head of cattle and 130,000 small ruminants. Most of the 
area currently infested with nagana is used for traditional mixed farming and the presence of 
tsetse and nagana seriously handicaps development. The Food and Agriculture Organization of 
the United Nations (FAO) has also recently become involved by providing limited assistance 
under a technical cooperation programme for the long-term control/eradication of 
trypanosomosis in KwaZulu-Natal. 
Survey 
Clinically the disease is present in its chronic form suggesting low fly challenge. Even though 
trypanosome infections were detected, failure to adopt formal random techniques and the low 
sensitivity of the method employed prevented accurate estimation of the prevalence of 
trypanosomosis in the region. ILRAD was consulted in 1993 to assist in designing an unbiased 
cross-sectional study of cattle trypanosomosis in northern KwaZulu-Natal, using a more 
sensitive and specific diagnostic technique-the antigen detection ELISA (Ag-ELISA)-to estimate 
the extent of the problem in the area and to help with decisions on control strategies. 
Recently specific monoclonal antibodies (MAb) were derived against non-variable trypanosomal 
antigens from in vitro propagated procyclic forms of T. congolense, T. vivax and T. b. 
brucei (Nantulya et al 1987). These antibodies were shown to detect species-specific circulating 
antigens in sera of infected cattle. The use of these specific MAbs in an antigen-trapping ELISA 
(Ag-ELISA) resulted in a sensitive and specific diagnostic test enabling many latent infections to 
be detected (Nantulya and Lindqvist 1989). Circulating antigens can be detected as early as 8–
14 days post-infection and persist probably as long as the infection persist in the animal 
(Masake et al 1995), but are cleared from the circulation within two weeks, following drug cure 
(Nantulya and Lindqvist 1989). False negative results have been reported early on in infections 
and may occur due to low levels of circulating antigens (Nantulya and Lindqvist 1989; Masake 
et al 1995). 
Table 1. Estimated prevalence of Trypanosoma spp infection in northern KwaZulu-Natal using 
Ag-ELISA and BCT. 
District  
No. of  
sections  
No. of  
samples 
Ag-ELISA BCT  
Trypanosoma spp 
(%) T. brucei  T. congolense T. vivax  
Ingwavuma  38  886  
0.389  
[0.336;0.443]†  
0.449  
[0.403;0.495]† 
0.336  
[0.271;0.402]† 
3.4 
Ubombo 43 1008 
0.352  
[0.292;0.412]  
0.455  
[0.386;0.524]  
0.332  
[0.281;0.383] 
  9.8 
Hlabisa  50  1138 
0.299  
[0.242;0.355]  
0.276  
[0.223;0.329]  
0.296  
[0.246;0.346]  
2.4 
Nongoma 6  134  0.328  0.366 0.299  3.7 
†95% confidence interval for the true prevalence. 
Sample design 
Each of the four districts at risk (Ingwavuma, Ubombo, Hlabisa and Nongoma) were divided into 
sections with one or more sections assigned to a diptank. There were a total of 137 sections 
and 106 diptanks (Table 1). A multistage sampling design was planned, with the primary unit 
being the section and the secondary unit, cattle. Twenty cattle were sampled per section and 
selected systematically as they went through the diptank. 
Samples 
Blood samples were collected in 10 ml vacutainer tubes, kept at ambient temperatures for a 
maximum of 24 hours (except in very hot [>30] areas). After clotting, the clot was removed, the 
sample centrifuged and the serum decanted into 2 ml plastic tubes and stored at -20°C before 
being tested with the Ag-ELISA or Latex agglutination test (only on some of the samples). 
Blood was also collected in capillary tubes (containing heparin as anticoagulant) and centrifuged 
to determine the PCV and then used to prepare buffy coat smears and examined by dark 
ground/phase contrast microscopy (also referred to as the buffy coat technique (BCT) (Murray 
et al 1977). A questionnaire was completed for each section sampled. 
Antigen-ELISA 
The Ag-ELISA was performed on all serum samples using monoclonal antibodies capable of 
capturing species-specific non-variable antigens of T. congolense, T. vivax and T. brucei, as 
described by Nantulya and co-workers (Nantulya et al 1987; Nantulya and Lindqvist 1989). 
Results 
A total of 3166 cattle, out of a population of 253,828 (= 1.2%), were sampled. The average PCV 
for the samples with a positive BCT result (n=139) was 32.1%, while the average PCV for the 
animals that tested negative (n=300) was 30.3%. It would therefore appear that the presence 
of Trypanosoma is unrelated to the PCV values in this study. 
The results of the BCT and Ag-ELISA are summarised in Table 1. Figure 1 summarises the 
geographical prevalence of Trypanosoma spp as determined with the Ag-ELISA. 
The Ag-ELISA revealed that T. brucei is also present in the animals and it would appear that T. 
congolense is more prevalent than T. brucei or T. vivax (although not statistically significant) at 
most diptanks. 
The results of the Ag-ELISA and Latex agglutination tests are compared in Figure 2. It is clear 
that there are discrepancies between the two tests, the Latex test only identifying ca 10% (for T. 
congolense and T. vivax) of Ag-ELISA-positive animals (52% in the case of T. brucei), while 
only 4–8% (T. congolense and T. vivax, respectively) of Ag-ELISA-negative animals tested 
positive with the Latex test (46% in the case of T. brucei). 
Discussion 
The diagnosis of trypanosomosis is notoriously difficult. Clinical signs are non-specific and 
parasitaemia is usually low and intermittent. Although the examination of blood smears alone is 
a relatively insensitive way to detect infection it is simple and of great practical significance as it 
can also be used to diagnose anaplasmosis, babesiosis and theileriosis. The most sensitive 
direct method of detecting T. congolense and T. vivax infections is by examination of wet 
preparations of the haematocrit buffy coat, under phase contrast illumination (Murray et al 
1977). 
Alternative laboratory approaches to diagnose trypanosomosis in animal populations are to 
demonstrate specific antibodies in the serum of infected animals for which several techniques 
have been described (reviewed by Nantulya 1990). Since antibodies persist for a long time, 
even after successful elimination of the infection in the animal (self cure or chemotherapy), 
these antibody detection techniques will only provide a presumptive diagnosis as it is not 
possible to distinguish between current and latent infections (Luckins et al 1979; Nantulya et al 
1984, 1986). Another major problem of using serological tests to detect trypanosome antibodies 
is the lack of specificity of the antigens used and cross reactions occurring 
between Trypanosoma spp. 
Although it is reported that the Ag-ELISA is four to five times more sensitive than conventional 
techniques (thick and thin blood smear and BCT) (Masake and Nantulya 1991; Masake et al 
1995) the estimated prevalence of trypanosomosis in KwaZulu-Natal appeared to be so much 
higher than expected that it appeared to in no way reflect the clinical position on the ground. 
Recent tsetse fly surveys in the area only collected G. austeni and G. brevipalpis and have also 
shown that the distribution of these fly species are much wider than generally accepted (i.e. 
distribution not confined only to dense, woody coverts, riverine thickets or forests) (E.M. Nevill, 
unpublished observations). The cut-off set for the Ag-ELISA (OD>0.05) seems to compromise 
the sensitivity and specificity (especially for T. brucei) of the test. Because population 
seroepidemiology may vary over time in different geographical regions, the cut-off should be 
adjusted based on local studies. There also seems to be a significant difference in the results of 
the Ag-ELISA and Latex agglutination tests. These apparent discrepancies result in severe 
problems in the interpretation and eventual control strategies. Many trypanosome-infected 
animals appear to be clinically normal and even if sub-clinical disease is present it may not be 
economical for treatment to be given. 
 Figure 2.  Comparison of the Latex and ag-ELISA tests for Trypanosoma spp. 
Other shortcomings of the Ag-ELISA test are: 
 The test was evaluated under ideal laboratory conditions (eg environmental 
temperatures), but this may not be tenable in other laboratories resulting in varying OD 
readings that do not fall within specifications. The test should be evaluated at a range of 
environmental temperatures and conditions. 
 The test also seems to be vulnerable to slight alterations in the quality of reagents and 
buffers, requiring standardisation (titration of reagents to determine optimal dilutions) 
each time it is performed, especially if the test is not done on a routine basis. 
 Each serum sample must be tested separately with each of the three monoclonal 
antibodies. 
On a national level diagnosis is essential for disease surveillance and monitoring and provides 
essential information for the formulation and execution of disease control programmes. Any 
surveillance programme should have a high probability of detecting a disease if it is present in a 
country or region. The techniques used in such a surveillance programme must be sensitive 
(detect true health), specific (minimum of false identification of a health status), be completed 
within reasonable time and be simple to perform. Accurate data is essential to place the tsetse 
fly and nagana problem in the broader context of socio-economic and agricultural development, 
natural resource management and land husbandry. 
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Summary 
Antigen-ELISA was employed in the diagnosis of trypanosome infection and determination of 
efficacy of a trypanocidal drug, cymelarsan, in eliminating Trypanosoma evansi infection in 
camels in Kenya. In this first study a polyclonal rabbit anti-T. evansi antibodies (RATE) and 
RATE-peroxidase conjugate were employed in a sandwich ELISA. In a second study in Kenya, 
anti-trypanosome specific murine monoclonal antibodies were used in a sandwich ELISA to 
evaluate the efficacy of a commercial Cypermethrin® dip for the control of Glossina 
pallidipes and bovine trypanosomosis on Taita Ranch. In a third study, these monoclonal-based 
sandwich ELISAs were used to assess the success of the Kenya-Uganda joint border tsetse 
and trypanosomosis control. Both ILRI and IAEA versions of Ag-ELISA were used for detection 
of trypanosome antigens in naturally infected cattle in Kenya. Before these various versions of 
ELISA were used, they were validated and standardised for relative sensitivity and specificity. 
Results obtained in the camel studies in Kenya showed a relative sensitivity of >74% and a 
specificity of >79% in diagnosing T. evansi infection using either CTVM or KETRI diagnostic 
kits. The ILRI version of ELISA gave a relative sensitivity of 82 and 90% for bovine 
trypanosomosis in Kenya and Uganda, respectively. It was hard to determine the specificity of 
this test in Uganda due to lack of negative controls, but in Kenya the test was 99% specific. On 
the other hand, the Vienna version of bovine antigen-ELISA was 100% specific in Kenya but 
only 8.5% sensitive, while in Uganda the test gave specificities of 95, 97 and 75% for T. brucei, 
T. congolense and T. vivax, respectively, and relative sensitivity for the three trypanosome 
species were 75, 30 and 65%, respectively. Based on these results and others from 
collaborating African countries, it was recommended that the Vienna version of antigen-ELISA 
be readjusted to improve on its relative sensitivity. The cymelarsen treatment was instituted 
based on antigenaemia resulting in the reduction of the number of positive cases from 75 to 
11% as revealed by Ag-ELISA. This subsequently led to total elimination of trypanosome 
antigens in camels. 
Introduction 
Animal trypanosomosis is endemic in more than 90% of Uganda and is the single most 
important disease constraint to livestock production (COCTU 1987) in that country. In Kenya, 
tsetse-transmitted trypanosomosis is endemic in 60% of Kenya's rangelands, which constitute 
25% of the country (KETRI 1990). Though large-scale eradication of tsetse and trypanosomosis 
may remain elusive for many years to come, the availability of low-cost technologies and 
prospects of community participation give optimism for the smaller, and more manageable 
tsetse and trypanosomosis programmes (Chadenga 1994). In the past, one of the major 
constraints to the control of trypanosomosis has been the lack of sensitive diagnostic tests. The 
recent development of tests which detect circulating trypanosomal antigens has given a ray of 
hope onto this predicament (Nantulya 1989, 1991). This paper discusses the results of studies 
carried out to evaluate the success of some of the smaller tsetse and trypanosomosis control 
programmes in Kenya and Uganda using antigen-ELISA (Nantulya and Lindqvist 1989). 
Materials and methods 
Antigen-ELISA for T. evansi infection in camels 
RATE and RATE-peroxidase conjugate were obtained from Edinburgh, UK. The T. evansi Ag-
ELISA was standardised using serum samples from known parasite-negative and parasite-
positive camels. Subsequently, the test was used to study the prevalence of trypanosome 
infection in five camel herds comprising 641 camels and to evaluate the efficacy of cymelarsan 
used for treating the KETRI camel herd (61 camels) based at Athi River, Kenya. Anti-T. 
evansi monoclonal antibody and corresponding peroxidase conjugate were prepared at KETRI. 
Antigen-ELISA for diagnosis of bovine trypanosomosis caused by T. 
brucei, T. congolense and T. vivax 
Reagents for bovine antigen-ELISA were either obtained from ILRI or IAEA. In Uganda, the 
study was conducted on sera collected from cattle herds located near the Kenya-Uganda border 
where tsetse and trypanosomosis control were being performed using spot-on (deltamethrin), 
block treatment with diminazene aceturate and deltamethrin impregnated traps or screens. In 
Kenya Ag-ELISA was conducted on sera collected from cattle subjected to experimental 
Cypermethrin® (Rhône Mérieux, France) dipping at Taita and Taru ranches. Trypanosome-
negative sera were obtained from cattle residing at KETRI (Muguga) and ILRI herd (Kapiti 
plains), comprising 60 and 200 samples. 
Parasitological diagnosis 
Buffy coat technique (BCT) was employed for parasitological diagnosis as described by Woo 
(1970). Trypanosomes were identified by microscopic examination of thin-stained blood smears. 
For theT. evansi studies mouse subinoculation was employed as described by Godfrey and 
Killick-Kendrick (1962). 
Results 
Table 1 shows the set-up of antigen-ELISAs which have been used in Kenya and Uganda for 
trypanosomal studies. Table 2 summarises the specificities and sensitivities of the ELISAs 
determined at KETRI, Kenya and at Livestock Research Institute (LIRI), Uganda for animal 
trypanosomosis. The CTVM T. evansi polyclonal-based ELISA gave fairly good relative 
sensitivity and specificity and on that basis was employed for epidemiological studies. In the five 
camel herds studied, results showed prevalence rates of T. evansi infection ranging from 45.5 to 
86% compared to 1 to 18% using parasitological tests. Higher ELISA OD values were observed 
in those herds with the highest rate of patent infection or where chemotherapeutic intervention 
was not being practised. However, the study revealed evidence of endemic trypanosomosis in 
all sampled herds and although treatment with quinapyramine sulphate suppressed 
parasitaemia, the presence of circulating trypanosomal antigens indicated the probable 
persistence of infection due to resistance to this drug. In experimental camels, the use of Ag-
ELISA in evaluating the efficacy of cymelarsan revealed that more than 80% of the treated 
camels were apparently cured as evidenced by the disappearance of parasites and 
trypanosomal antigens from the blood circulation. However, relapses were observed in a few 
animals. Antigenaemia persisted in a number of the camels throughout the study period. 
Treatment on the basis of an antigenaemia reduced the proportion of ag-positive animals from 
75 to 26% and parasites remained undetectable up to the end of the study. 
Table 1. Types of antigen-ELISA used in Kenya and Uganda. 
Coating 
antibody 
Blocking 
agent  Conjugate Chromogen Institution  
Country 
of 
origin 
RATE  1% BSA RATE-PO  TMB CTVM Kenya 
T.e. MAb None T.e.-PO OPD KERTI Kenya 
T.b. MAb  1% BSA T.b.-MAb-PO ABTS ILRI Uganda 
T.c. MAb  1% BSA T.c.-MAb-PO ABTS ILRI Uganda 
T.v. MAb  0.5% NMS T.c.-MAb-PO ABTS ILRI Uganda 
T.b. MAb 0.5% NMS T.b.-MAb-PO TMB IAEA Uganda 
T.c. MAb 0.5% NMS  T.c.-MAb-PO TMB IAEA Uganda 
T.v. MAb  0.5% NMS  T.v.-MAb-PO  TMB IAEA Uganda 
T.b. MAb 0.5% NMS T.b.-MAb-PO TMB ILRI Kenya 
T.c. MAb  0.5% NMS  T.c.-MAb-PO TMB ILRI Kenya 
T.v. MAb 0.5% NMS T.v.-MAb-PO TMB ILRI Kenya 
RATE = rabbit anti T. evansi; T.e. MAb = monoclonal antibody against T. evansi; T.b. = T. brucei; T.c. 
= T. congolence; T.v. = T. vivax; BSA = bovine serum albumin; PO = peroxidase; NMS = normal mouse 
serum; TMB = tetra methyl-benzidine; ABTS = 2,2'-azino di [3-ethylbenzthiazoline] sulphonate; OPD = 
Othophenylenediamine. 
Table 2. Relative sensitivity and specificity of the antigen-ELISAs used in Kenya and Uganda. 
Species/institution   
of origin 
Relative 
sensitivity† (%)  Specificity (%) Country 
T. evansi/CTVM  74 79 Kenya 
T. evansi/KETRI 92  100 Kenya 
T.b.-ILRI – 99 Kenya 
T.c.-ILRI 83  99 Kenya 
T.v.-ILRI 80  99 Kenya 
T.b.-IAEA 75 95  Uganda 
T.c.-IAEA 30 97 Uganda 
T.v.-IAEA 65 75 Uganda 
T.b.-IAEA – 98 Kenya 
T.c.-IAEA 30 100 Kenya 
T.v.-IAEA  18.3 99 Kenya 
 BCT = buffy coat technique. 
In another study an IgM trypanosome-specific monoclonal antibody raised against T. 
evansi, MAb TEA1/23.4.6. was used to study T. evansi infection in goats and camels. 
Trypanosomal antigens were detected in infected goats 24 hr after intravenous inoculation of 2 
× 106 trypanosomes/goat and although the levels of parasitaemia fluctuated, positivity was 
maintained throughout the course of infection. Following treatment, antigens concentration 
dropped to undetectable levels between 7 and 48 days. The same trend was observed in 
infected camels which were effectively treated. On the contrary there was an elevation of 
circulating trypanosomal antigens several weeks prior to reappearance of trypanosome in blood 
circulation. 
The ILRI antigen-ELISA used for bovine trypanosomosis in Uganda gave a relative sensitivity of 
91% based on 118 parasitologically positive cattle. In sampled herds the test revealed evidence 
of mixed infection and a higher prevalence of the disease than parasitological tests based on 
microscopic examination. In areas where 1% deltamethrin (Spot-on®, Cooper, Harare, 
Zimbabwe) had been applied, there was marked reduction of infection from about 10 to 0% by 
BCT, and 75 to 15% by antigen-ELISA, while in the areas where tsetse control was not being 
practised the disease incidence remained elevated. 
In a subsequent study in Uganda using IAEA modified antigen-ELISA, a total of 3035 cattle 
(2733 from a tsetse-infested area and 302 from a tsetse-free area) were screened by both BCT 
and antigen-ELISA. The observed specificities of antigen-ELISA for T. brucei, T. 
congolense and T. vivax were 95, 97 and 75%, respectively, while sensitivities for the same 
trypanosome species were 75, 30 and 65%, respectively. 
In Kenya, the results of the ILRI version of antigen-ELISA used to evaluate the efficacy of 
Cypermethrin dip for the control of Glossina pallidipes gave a specificity of 100% for the three 
species and sensitivities of 80% for T. vivax and 83% for T. congolense. Trypanosoma brucei 
infections were not detected parasitologically. The study showed a marked reduction in 
trypanosome infection on the ranch where Cypermethrin dip was applied (Taita Ranch) as 
opposed to the control ranch (Taru Ranch) where there was no fly control. The IAEA version of 
antigen-ELISA gave specificities of 100, 98 and 99% for T. congolense, T. brucei and T. 
vivax, respectively, and relative sensitivities of 1 and 18.5% for T. congolense and T. 
vivax, respectively. No T. brucei infections were detected parasitologically by BCT. 
Discussion and recommendation 
Studies carried out on the use of antigen-ELISA in Uganda and Kenya demonstrate the 
usefulness of combining serological diagnosis with tests based on parasite detection for the 
control of animal trypanosomosis. Fairly good relative sensitivity and specificity was achieved 
with most tests except for IAEA version of antigen-ELISA which suffered from low relative 
sensitivity. 
However, in order to achieve internationally accepted standards, these tests could be improved 
in the following ways. Firstly, the sample sizes used for standardisation and validation were in 
most cases too small. This means that the sensitivities recorded cannot be relied on. Secondly 
there was a problem of obtaining true negatives. Given the fact that antigen-ELISA is more 
sensitive than the parasite detection tests (Nantulya 1989) there was the definite lack of a 
'goldstandard' test for comparison. This shortcoming could be overcome by using PCR in 
addition to parasitological tests. Before PCR is developed, standardised and validated for 
routine trypanosomosis diagnosis, the problem of specificity and relative sensitivity might linger 
on for some time to come. It is apparent that most of the monoclonal antibody probes used in 
these studies are of IgM class. Since the latter tend to give non-specific reactions, attempts 
should be made to generate MAbs of IgG class. By paying attention to the analytical requisites, 
diagnostic performance, standards and quality control, the performance of trypanosomal 
antigen-ELISA can be greatly improved. 
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Summary 
The antigen-detection ELISA (Ag-ELISA) test proposed by ILRI for the diagnosis of 
trypanosomosis has been evaluated in a comparative study of the susceptibility to trypanosomal 
infections in experimentally infected sheep and goats, and in an observational study 
implemented in Pays Lobi in Burkina Faso, a trypanosomosis endemic area, and in Markoye, a 
tsetse-free zone located in the north. The Ag-ELISA, according to the protocol of IAEA, was 
evaluated in a cross-sectional study in south western and northern Burkina Faso and during the 
monitoring of a trypanosomosis-control programme in the pastoral zone of Yalé. Low 
sensitivities were found for both kits, and for Trypanosoma vivax were as low as 10% across the 
different studies. Different batches of the IAEA kit were also compared and showed inconsistent 
results. 
Introduction 
The antigen-detection ELISA (Ag-ELISA) test, proposed by Nantulya and Lindqvist (1989), was 
described to be a useful tool for the diagnosis of trypanosomosis, particularly in chronic 
infections (Masake and Nantulya 1991) and in monitoring the effectiveness of a trypanocidal 
treatment (Nantulya and Lindqvist 1989). From 1990 to 1996 the two different designs of the 
test proposed by ILRI and IAEA have been evaluated within epidemiological studies 
implemented by Centre International de Recherche-Dévéloppement sur l'Elevage en zone 
Subhumide (CIRDES). This is a summary of the results. 
Materials and methods 
Evaluation of the kits from ILRI 
This exercise has been implemented in a comparative study of the susceptibility to 
trypanosomal infection of experimentally infected sheep and goats, and in an observational 
study carried out in Pays Lobi, a trypanosomosis-endemic area. The methodology consisted of 
comparing the Ag-ELISA and buffy coat/contrast phase (BCT) tests (Murray et al 1977) by a 
systematic application of both methods to the same samples. Three hundred and thirteen 
samples were collected and investigated in the experimental study and 1633 in the field study. 
Fifty sera from a tsetse-free area in the north of Burkina Faso and 49 sera from Germany, 
respectively, were also tested. 
Evaluation of the kits from IAEA 
The kit design proposed by IAEA has been evaluated in 2362 samples collected in south 
western and 320 in northern Burkina Faso systematically applying the Ag-ELISA, BCT and the 
thin smear technique (TST) to the same samples. Nine hundred and sixty one samples were 
investigated in a study that monitored the dynamics of infection status in cattle following 
treatment with diminazene aceturate in a tsetse-control operation with deltametrin in the 
pastoral zone of Yalé. Forty sera have also been tested using different IAEA Ag-ELISA kits. 
Statistical analysis 
For studies using ILRI's kit statistical analysis consisted of determining the co-association, 
sensitivity and specificity of results from the Ag-ELISA in comparison with the BCT following the 
procedure described by Masake and Nantulya (1991). For IAEA's design, the Ag-ELISA test 
was compared to BCT and TST by means of kappa statistics. 
Results and discussion 
ILRI kits 
In the experiment with T. congolense-infected small ruminants, antigens were detected following 
parasitaemia, showing a peak following a decrease. However, in T. vivax-infected groups 
antigenaemia remained below the threshold. The apparent sensitivity was 63% for T. 
congolense infection and only 10% for T. vivax; sensitivities for BCT were 55 and 49% for T. 
congolense and T. vivax, respectively. 
Of the 1633 samples collected in Pays Lobi, BCT detected 8.8% positive samples. Of these 144 
samples Ag-ELISA detected only 76% of the 51 T. congolense-BCT-positive and only 17% of 
the 93 T. vivax-BCT-positive. The predominant trypanosomal species identified by BCT was T. 
vivax followed by T. congolense whereas Ag-ELISA identified mostly T. congolense followed 
by T. brucei. 
The analyses of the 50 samples from a tsetse-free area in the north of the country gave an 
apparent specificity of 98%. None of the 49 sera from Germany was positive. The low sensitivity 
of the kits from ILRI for T. vivax in experimental infections has been previously reported (Kanwé 
et al 1993). Further investigations in naturally occurring infections have confirmed these 
observations (Bengaly et al 1995). 
Table 1. Values of kappa statistics between ILRI Ag-ELISA test and parasitological (buffy coat 
and thin smear) techniques. 
Ag-ELISA 
Trypanosome 
species 
Buffy coat technique 
Thin smear 
technique 
Overall T. brucei 0.00 0.00 
  T. congolense  0.06 0.01 
  T. vivax 0.04 0.00 
Kit A T. congolense  0.07  –0.06 
  T. vivax 0.08 0.03  
Kit B T. congolense  0.07 0.06 
  T. vivax 0.03 –0.01 
Table 2. Mean PCV by trypanosomal infection status as determined by different diagnostic 
methods in cattle in Burkina Faso. 
Diagnose method 
Infection status 
Negative  Positive 
BCT  31.7 ± 5.2†  25.6 ± 6.4 
TST 31.1 ± 5.4  26.7 ± 6.2 
Ag-ELISA  31.9 ± 5.2  30.2 ± 5.9 
†Standard deviation. 
IAEA kits 
Kappa statistics computed between Ag-ELISA and BCT or TST applied to the 2362 samples 
collected in south western Burkina Faso were below 0.07 for the different species. These data 
showed a lack of agreement between the Ag-ELISA and microscopic methods. 
Further analyses which took into account kit batch did not improve agreement between the 
methods (Table 1). Indeed, values of kappa statistic of -0.25, 0.19 and 0.0 for T. brucei, T. 
congolense andT. vivax, respectively, were recorded between two batches of kits, applied to the 
same 40 sera. The apparent sensitivities were 37 and 33% for T. congolense and T. 
vivax infections, respectively. The apparent specificity, resulting from analyses of 320 samples 
from a tsetse-free area in northern Burkina Faso, was 100% for T. brucei and T. 
congolense and 99.7% for T. vivax. 
In the agropastoral zone of Yalé, the monitoring of animal infection status by BCT showed a 
marked decrease in prevalence of T. congolense and T. vivax which was contrary to levels 
obtained by Ag-ELISA (Figure 1). Buffy coat technique and TST results were also more closely 
correlated with packed cell volume (PCV) than were the results of the Ag-ELISA test (Table 2). 
 Figure 1. Kinetic of the prevalence based on Ag-ELISA and buffy coat techniques in groups of 
animals infected with different trypanosome species. 
Conclusion 
Epidemiological surveys carried out by CIRDES during the last five years have shown 
inconsistencies between ILRI and IAEA designs of the Ag-ELISA test when compared with BCT 
and TST. The infection status of samples negative by BCT or TST but positive by Ag-ELISA test 
is unclear. The hypothesis that lymphoid nodes and cephalo-rachidien liquid in such samples 
may contain trypanosomes needs further study. The polymerase chain reaction (PCR) 
technology applied to such samples might also clarify their infection status. 
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Summary 
The performance of a trypanosomal antigen-detection ELISA (Ag-ELISA) and a trypanosomal 
antibody-detection ELISA (Ab-ELISA) was evaluated. The Ag-ELISA had low sensitivity. The 
Ag-ELISA using dried blood spots as antibody source, on the other hand, performed well and is 
believed to have potential as a practical diagnostic test in trypanosomosis surveys. 
Nevertheless, more development work will have to be done to standardise the trypanosomal Ab-
detecting ELISA and determine its performance parameters. 
Introduction 
In Zimbabwe, tsetse-transmitted trypanosomosis is a severe threat to the livestock industry. For 
the past decades, intensive tsetse control operations have pushed the tsetse front back to 
Zimbabwe's eastern and north-eastern borders (Figures 1and 2). Current tsetse-control 
strategies involve the use of insecticide-treated, odour-baited targets and, insecticide-treated 
mobile baits (Shereni 1989). Nevertheless, Zimbabwe's impressive achievement in controlling 
tsetse is continuously threatened by tsetse invading from neighbouring countries. In view of this, 
a Regional Tsetse and Trypanosomosis Control Programme (RTTCP) was initiated with the aim 
to control tsetse in the fly-belt common to Malawi, Mozambique, Zambia and Zimbabwe. 
Various methodologies have been used to monitor the success of tsetse control operations in 
the RTTCP region. Tsetse surveillance methods are not very sensitive, especially for Glossina 
morsitans morsitans. This makes an objective evaluation of the tsetse situation difficult. To 
complement entomological surveys, when low-density vector populations are present, 
trypanosomosis surveys can be conducted. In most cases use is made of direct parasitological 
diagnostic tests (Paris et al 1982). The clear limitation, from a diagnostic point of view, of 
parasitological tests to detect infected animals promoted the development of indirect methods, 
mainly immunodiagnostic techniques. The development of enzyme-linked immunosorbent 
assays (ELISA) for diagnosing tsetse-transmitted trypanosomosis has shifted the emphasis 
even more on immunodiagnosis rather than parasitological diagnosis. Currently, ELISAs have 
been developed for the detection of either trypanosomal antigens or trypanosomal antibodies. 
Both tests could be very useful diagnostic tests in trypanosomosis surveys and/or surveillance. 
However, their performance still needs to be evaluated before their routine use can be 
promoted. This paper describes the work conducted in Zimbabwe on the evaluation of both 
diagnostic tests. 
 Figure 1. Tsetse limit in the past. 
Materials and methods 
The trypanosomal antigen-detection ELISA (Ag-ELISA) 
The Ag-ELISA was evaluated using reagents and protocols from both the International 
Livestock Research Institute (ILRI) and the International Atomic Energy Agency (IAEA). 
Blood was collected from cattle in tsetse-free and tsetse-infested areas of Zimbabwe. All 
samples were examined for the presence of trypanosomes using parasitological methods (buffy 
coat method). The sera were stored at -20°C until use. The circulating trypanosomal antigens 
were detected in the sera using a sandwich enzyme-linked immunosorbent assay as described 
by Nantulya and Lindqvist (1989). Mouse monoclonal antibodies specific for Trypanosoma 
brucei, T. congolense and T. vivax antigens were used. Bench protocols were strictly followed. 
 Figure 2. Current tsetse limit and control areas. 
The trypanosomal antibody-detection ELISA (Ab-ELISA) 
Bovine blood was collected in tsetse-infested areas in Zambia and tsetse-free areas in 
Zimbabwe. Blood was collected from an ear vein into heparinised microhaematocrit centrifuge 
capillary tubes. Blood contained in one heparinised microhaematocrit centrifuge capillary tube 
was extruded onto a filter paper (Whatman No. 4, Whatman®). Samples were air-dried out of 
direct sunlight, placed in a plastic bag with self-indicating silica gel desiccant; the bag was 
sealed and kept as cool as possible until specimens were refrigerated or frozen. 
Table 1. Results of negative population testing using IAEA test. 
Area 
 No. of 
cattle 
tested 
No. of 
negatives 
Negative 
%  
T.c. T.b./T.c. T.v. 
Nyaguwe 46 35 76 0 1 10 
Koyoyo 50 43 86 1 0 6 
Nora 50 43 86 1 1 5 
Commercial 
farm 
94 91 97 0 0 3 
Eluted blood spots were screened for the presence of anti-trypanosomal antibodies using an 
indirect anti-trypanosomal Ag-detection ELISA (Luckins 1977). Use was made of a T. 
congolense (IL 3000) invariable antigen batch prepared by the Parasitology Laboratory of the 
Department of Paraclinical Studies of the School of Veterinary Medicine, University of Zambia. 
A rigorous system of quality assurance was adopted. Hence, each ELISA-microplate was run 
with strong positive, weak positive and negative reference sera that were required to comply 
with pre-set values. The optical density (OD) of each ELISA sample tested was expressed as a 
percentage (percentage positivity, PP) of the strong positive reference standard. 
Results 
The Ag-ELISA 
The prevalence of T. brucei infections was high in samples analysed using both Ag-ELISAs. 
This high prevalence of T. brucei infections in areas where tsetse has never been and never will 
be present is incompatible with the epidemiology of tsetse-transmitted trypanosomosis. The 
majority of those infections were, therefore, considered false positives. Moreover, the tests had 
low sensitivity resulting in serological negative results of parasitologically positive (T. 
vivax and T. congolense) samples. 
Modification of the IAEA Ag-ELISA resulted in improved specificity. The seroprevalence of 
trypanosomosis in sera collected from 240 cattle from several tsetse-free areas in Zimbabwe 
(communal areas and a commercial farm) varied between 3 and 24% (Table 1). 
According to the above results the specificity of the test was: 
        T. brucei             99.2% 
        T. congolense    98.3% 
        T. vivax              90.9% 
The main problem encountered with the IAEA antigen-ELISA was the instability of the 
conjugate. This was especially the case for the T. vivax conjugate whose potency decreased 
with time (Figure 3). 
Moreover, in order to obtain repeatable results freshly distilled water had to be used. 
 Figure 3. OD values for T. vivax controls using antigen ELISA test four times for each of two 
conjugate dilutions. 
 
Figure 4. Frequency distribution in percentage positivity of antibody ELISA values of 160 known 
positive and negative blood spot samples. 
Table 2. Mean and standard deviations of ELISA values of known positive and negative 
samples. 
  
OD values Percentage positivity 
Negative  Positive Negative  Positive 
Mean 0.107 0.589 9.94 43.15 
SD 0.028  0.370    2.79 27.93 
The antibody-ELISA 
Preliminary work with the antibody-ELISA indicated a clear discrimination between the 
distribution of the OD values of approximately 50 parasitological positive and approximately 50 
parasitological negative samples (Figure 4). Table 2 summarises the average OD values and 
PP of these samples. 
The test's performance largely depended on the quality of the water used. As is the case for the 
Ag-ELISA, freshly distilled and deionised water should be used. This results in the 
inconvenience of making fresh buffers almost on a daily basis. 
To standardise the test, use was made of a batch of antigen of which large quantities are 
available. Moreover, large batches of strong positive and negative sera have been prepared and 
will continue to be used as reference sera. 
Conclusion and discussion 
Our observations confirm the low sensitivity of the Ag-ELISA. Its value in detecting tsetse-
transmitted trypanosomal infections during trypanosomosis surveys/surveillance is, therefore, 
questionable. 
Although the Ab-ELISA has not yet been used for testing large numbers of field samples, it is 
believed to have potential in trypanosomosis surveys to determine the spread of the disease. Its 
use as a tool to evaluate the effect of tsetse control operations on the transmission of 
trypanosomosis will need more research into the dynamics and persistence of trypanosomal 
antibodies. The use of eluted blood spots as an antibody source has certainly improved the 
sustainability of Ab-ELISA. This particular modification has the significant advantage that 
samples do not have to be kept at low temperatures facilitating sample storage and sample 
transportation. Nevertheless, more development work will have to be done to standardise the 
test and determine its performance parameters. 
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Summary 
Two antigen detection ELISAs (Ag-ELISA) for Trypanosoma evansi were extensively evaluated 
in Indonesia in experimental animals and in field trials to determine their sensitivity and 
specificity. In experimentally infected buffalo, the development of antigenaemia varied according 
to the strain of trypanosome used for infection, the individual animal, the period of infection and 
the particular epitope recognised by the monoclonal trapping antibody. In a primary infection, 
antigens were detected as early as 7 days after infection or as late as 42 days. Following 
treatment with trypanocidal drug, antigens declined in some buffalo within 12–47 days. A similar 
pattern of responses was seen when the buffalo were infected with a heterologous strain of T. 
evansi. Serum antibody assays were carried out using IgM- and IgG-ELISAs and card 
agglutination tests (CATT). Antibodies were detected by 7–42 days after infection and 
disappeared slowly after treatment. Estimates of the diagnostic sensitivity of the different tests 
during the course of infection in experimentally infected animals showed considerable variation, 
with maximum sensitivity of the Ag-ELISAs being achieved about 42 days after primary infection 
and between 50 and 64 days after secondary infection. A similar pattern of sensitivity was 
shown by IgM- and IgG-ELISA and CATT tests. For field use, estimations of sensitivity were 
based on the results obtained from sera collected from naturally infected buffalo and specificity 
on the results of assays on sera from Australian buffalo. For the Ag-ELISAs, sensitivity 
estimates varied between 67 and 82% and diagnostic specificity was between 75 and 78%. 
Introduction 
Several MAbs have been developed at CTVM and ILRI, which specifically recognise antigenic 
determinants present only in trypanosomes of the sub-genus Trypanozoon and while 
monoclonal antibodies have been used in Ag-ELISAs for the diagnosis of African 
trypanosomoses for a number of years (Rae and Luckins 1984; Nantulya and Linquvist 1989; 
Nantulya et al 1987; Masake and Nantulya 1991) there has been little attempt at their proper 
validation in terms of quality assurance and determination of diagnostic sensitivity and 
specificity for use in diagnosis of Trypanosoma evansiin S.E. Asia. The aim of the present study 
therefore was to evaluate the two Ag-ELISAs for the detection of T. evansi infections in 
individual Indonesian buffaloes and the ability of the assays to monitor parasite clearance after 
chemotherapy. In order to achieve this, buffaloes were experimentally infected with T. 
evansi and treated with a trypanocide to: 1) obtain profiles of antigenaemia of individual 
buffaloes, 2) determine when antigenaemia is first detectable post-infection, 3) determine the 
frequency with which individual buffaloes and groups of buffaloes are positive by weekly Ag-
ELISAs compared with other diagnostic tests, 4) monitor changes in the level of antigenaemia 
after chemotherapy and 5) determine the diagnostic sensitivity and specificity of the tests in field 
studies in Indonesia. 
Materials and methods 
Two MAbs (2G6 MAb and Tbr7 MAb) were chosen for use in the T. evansi Ag-ELISA; 2G6 MAb 
from CTVM is an IgG fraction derived from MAbs against T. evansi which recognises a 70 kDa 
antigen; Tbr7 MAb from ILRI is an IgM fraction derived from MAbs against T. b. 
rhodesiense which recognises a 15 kDa antigen. Assays were standardised using high binding, 
96-well microtitre ELISA plates (Immulon 2, Dynatech M129B). Plates were coated with trapping 
MAb diluted in 0.05 M carbonate-bicarbonate buffer, pH 9.6 shaken at ambient temperature for 
30 seconds to ensure even distribution of the MAb and then stored overnight at 4°C. The 
following day, plates were washed with phosphate buffered saline, pH 7.4, containing 0.05% 
Tween 20 (PBS/0.05T). Test samples and control sera were diluted with PBS containing 
PBS/0.50T; test serum samples were added in duplicate, and high and low positive (C++, C+), 
negative (C-) and conjugate (Cc) controls (diluent buffer only) were included on each plate. After 
incubation at 37°C for 30 minutes, the plates were washed as before. The monoclonal 
antibodies conjugated with horseradish peroxidase were diluted with PBS/0.50T and added to 
the plates which were shaken at 37°C for 30 minutes. After washing, the substrate/chromogen 
solution, tetramethylbenzidine dihydrochloride/H2O2 was added, the plate incubated for 10 
minutes at 37°C, the enzymatic reaction stopped by addition of 2 M sulphuric acid and the OD 
read at 450 nm. Absorbance values were expressed as percent positive values (PP). Upper 
(UCL) and lower (LCL) control limits for the Ag-ELISA control sera were determined by assaying 
multiple replicates of the different control sera; the 10 and 90% percentile values were chosen 
as the lower and upper control limits respectively because the data did not have a normal 
distribution. 
Two isolates of T. evansi were used for the experimental infections: an isolate of low 
pathogenicity, T. evansi Bakit 259 from East Java, was used for a primary infection and a more 
pathogenic isolate,T. evansi Bakit 362 from Madura Island, for secondary infection. Each buffalo 
was intravenously injected with 2 × 107 trypanosomes. Thirty five buffaloes were infected 
with T. evansi Bakit 259 and monitored for 105 days before treatment with the trypanocidal 
drug, cymelarsen. Following chemotherapy, all buffaloes were injected intravenously with T. 
evansi Bakit 362 and monitored for 64 days before treatment. Weekly serum samples were 
tested by Ag-ELISA, IgM-ELISA, IgG-ELISA and CATT and blood samples by the 
microhaematocrit centrifugation test (MHCT), mouse inoculation (MI) and wet blood film 
examination. 
For the field studies, five visits to northern Central Java were made over a 24-month period and 
during each visit approximately 100 buffaloes were sampled from each of five districts (Batang, 
Pekalongan, Pemalang, Tegal and Brebes). To obtain estimates of diagnostic specificity for the 
serological tests, sera were assayed from 263 Australian buffalo and 80 Australian cattle which 
had never been exposed to trypanosomosis risk, whilst for diagnostic sensitivity, sera from 
naturally infected Indonesian buffalo were used. 
Results and discussion 
Diagnostic specificity 
The diagnostic specificity estimates obtained from buffalo and cattle sera and calculated with 
associated 95% confidence intervals for both Ag-ELISAs and for Ab-ELISAs are shown in Table 
1. The specificity of 2G6 Ag-ELISA was similar to the specificity of Tbr7 Ag-ELISA using buffalo 
sera but was significantly lower using cattle sera (p<0.001), at both cut-off values. Specificity 
estimates were significantly higher for Tbr7 Ag-ELISA (p<0.01) and for 2G6 Ag-ELISA (p<0.05) 
at the 30% cut-off value. The underlying cause of the false positive results obtained with the two 
ELISAs is not known. The specificity of the CATT was 100% (97, 100) which was significantly 
higher than the estimates obtained for the IgM- and IgG-ELISAs (p<0.001) and the IgG-ELISA 
specificity was significantly higher than the IgM-ELISA specificity (p<0.001) (Table 1). The 
specificity estimates of both the IgM- and IgG-ELISAs were significantly higher using the higher 
cut-off value (p<0.001). 
Diagnostic sensitivity—experimental studies 
Ag-ELISAs 
There were three major types of antigen response: 1) development of antigenaemia, 2) no 
antigen detectable or 3) persistence of pre-infection antigenaemia. Antigenaemia was first 
detected 7 to 42 days after the primary and secondary infections by both the 2G6 Ag-ELISA and 
Tbr7 Ag-ELISA. Some buffaloes had similar 2G6-specific and Tbr7-specific profiles of 
antigenaemia whereas in other buffaloes the two antigens appeared at different stages of 
infection, with differences in the pattern of development of antigenaemia. Both Ag-ELISAs 
detected peaks of antigenaemia in many buffaloes from 42 days post-infection and declining 
antigen levels thereafter. Estimates of sensitivity of the 2G6 Ag-ELISA and Tbr7 Ag-ELISA 
calculated for different stages of the secondary T. evansi Bakit 362 showed the sensitivity of the 
Tbr7 Ag-ELISA was 83% at 15 days post-infection and was significantly higher compared with 
the 2G6 Ag-ELISA at 15 to 36 days post-infection (p<0.05). For both Ag-ELISAs, the highest 
sensitivity estimates were obtained 57 to 64 days post-infection. The observed differences in 
sensitivity reflect the underlying fluctuations in serum trypanosomal antigens that occur in 
buffaloes. Previous studies have reported clearance of T. vivax and T. congolense antigens 
within two weeks and of T. brucei antigens within four weeks of treatment with a trypanocidal 
drug (Nantulya and Lindqvist 1989). However in the present study, antigen clearance was much 
more variable and in some buffaloes antigenaemia persisted after treatment for up to 74 days 
after the primary infection and up to 8 months after the secondary infection, suggesting that 
these Ag-ELISAs may have limitations for the differentiation of active T. evansi infections from 
previous exposure to the parasite. 
 
 
 
 
 
 
Table 1. Estimates of diagnostic specificity (%), with 95% confidence intervals (CI), for (A) the 
2G6 Ag-ELISA and Tbr7 Ag-ELISA and (B) for the IgM-ELISA and IgG-ELISA, using sera from 
Australian buffaloes (n=263) and cattle (n=80). 
(A) 
Ag-ELISA Species  
20% PP cut-off  30% PP cut-off  
Specificity (%) 95% CI  Specificity (%)  95% CI 
2G6 Buffalo  75  (70, 80) 83  (79, 88) 
Tr7  Buffalo 78  (73, 83) 87 (83, 91) 
2G6 Cattle  68 (56, 78) 70 (59, 80) 
Tbr7  Cattle  100  (96, 100) 100 (96, 100) 
(B) 
Ag-ELISA 
20% PP cut-off  30% PP cut-off  
Specificity  95% CI  Specificity (%)  95% CI 
IgM  55 (46, 64) 89  (83, 94) 
IgG 92 (86, 96) 98 (94, 100) 
  
Antibody assays 
There was a wide range of serum antibody responses in individual buffaloes. Buffaloes were 
positive by antibody-detection tests by 7 to 42 days post-infection, but by contrast with the Ag-
ELISAs usually remained positive, particularly by the IgG-ELISA, throughout the remainder of 
the monitoring period. In some buffaloes antibody responses were low and not all antigenaemic 
buffaloes had antibody responses. In the primary infection, the sensitivity of the IgM-ELISA was 
higher compared with the IgG-ELISA and CATT on most sampling dates post-infection. The 
IgM-ELISA had a sensitivity of 50% on day 7 post-infection whereas the sensitivity of the IgG-
ELISA increased more slowly but was higher in the later stages of infection. The sensitivity of 
the CATT increased slowly, but unlike the IgG-ELISA, declined after 56 days post-infection. 
With the IgM-ELISA and IgG-ELISA, the highest sensitivity estimates were obtained 50 to 64 
days post-infection. The CATT had maximal sensitivity 15 to 29 days post-infection. In the 
primary infection, the ranking of the different diagnostic tests in descending order of frequency 
of positive results was CATT>MI>IgG-ELISA> IgM-ELISA>2G6 Ag-ELISA>Tbr7 Ag-
ELISA>MHCT for buffaloes shown to be parasitaemic. In this group of buffaloes, 25% (19, 30) 
of all weekly samples were positive by 2G6 Ag-ELISA compared with 15% (11, 20) by Tbr7 Ag-
ELISA. By antibody-detection tests, 34% (28, 41) of all weekly samples of parasitaemic 
buffaloes were positive by IgM-ELISA and IgG-ELISA, and 55% (48, 61) were positive by CATT. 
In the secondary infection, 54% (47, 62) of all weekly samples from parasitaemic buffaloes were 
positive by 2G6 Ag-ELISA compared with 76% (69, 82) by Tbr7 Ag-ELISA, 54% (47, 62) by 
IgM-ELISA, 82% (76, 87) by IgG-ELISA and 76% (70, 82) by CATT. The ranking of the tests in 
descending order of frequency of positive tests for secondary infection was IgG-
ELISA>CATT>Tbr7     Ag-ELISA>MI>2G6    Ag-ELISA>IgM-ELISA>MHCT. 
Diagnostic sensitivity—field studies 
During the field work in Central Java, 139 buffaloes were found to be naturally infected with T. 
evansi by MHCT (n=39) and by MI (n=100). All these sera were tested by the 2G6 and Tbr7 Ag-
ELISAs as well as IgM-ELISA, IgG-ELISA and CATT tests and estimates of their sensitivity 
calculated. The diagnostic sensitivity of the 2G6 Ag-ELISA and Tbr7 Ag-ELISA were estimated 
based on results of MHCT, or MI, or a combination of these tests, as shown in Table 2. Using 
buffaloes positive by MHCT alone, the Tbr7 Ag-ELISA had a significantly higher sensitivity than 
the 2G6 Ag-ELISA using a 20% cut-off value (p<0.05) and a 30% cut-off value (p=0.01); the 
sensitivity of the 2G6 Ag-ELISA was higher at the 20% cut-off value (p<0.05) but the sensitivity 
of the Tbr7 Ag-ELISA did not differ significantly. The diagnostic sensitivities of the IgM-ELISA, 
IgG-ELISA and CATT were also estimated on the basis of being positive by MHCT, MI or a 
combination of these tests (Table 3). For these different buffalo groups, the sensitivity estimates 
of the CATT were 79 (70, 87), 77 (61, 89) and 78% (72, 85), respectively. Using MHCT-positive 
buffaloes alone, the IgG-ELISA had a significantly higher sensitivity (p<0.05) compared with the 
CATT and there was a significant reduction in the sensitivity of the IgM-ELISA (p<0.05) but not 
of the IgG-ELISA, by using the higher cut-off value. Using MI-positive buffaloes, there was no 
significant difference between the sensitivity estimates obtained. Using MHCT- and MI-positive 
buffaloes, both IgM and IgG-ELISAs had a sensitivity significantly higher than the CATT 
(p<0.001) and the sensitivity of the IgM-ELISA was significantly lower at the higher cut-off value 
(p<0.001) but not for the IgG-ELISA. The results suggest that these Ag-ELISAs could be used 
as screening tests for groups of buffaloes in trypanosomosis endemic areas but would not be 
suitable for the diagnosis of T. evansi infections in individual buffaloes. 
Table 2. Estimates of diagnostic sensitivity (%), with associated 95% confidence intervals (CI), 
for the 2G6 Ag-ELISA and Tbr7 Ag-ELISA using sera from Indonesian buffaloes shown to be 
naturally infected with Trypanosoma evansi by (A) microhaematocrit technique (n=100), (B) 
mouse inoculation (39) and (C) either microhaematocrit technique or mouse inoculation (139). 
Test  
20% PP cut-off  30% PP cut-off 
Sensitivity (%)  95% CI  Sensitivity (%) 95% CI 
(A)   
  2G6 Ag-ELISA   
  Tbr7 Ag-ELISA 
 
67  
80 
 
(57, 76)   
(71, 87)  
 
51  
69 
   
(41, 61)  
(59, 78) 
(B)  
  2G6 Ag-ELISA   
  Tbr7 Ag-ELISA  
 
79   
82  
 
(64, 91)   
(67, 93) 
 
67  
77 
 
(50, 81)  
(61, 89) 
(C)  
   2G6 Ag-ELISA  
   Tbr7 Ag-ELISA 
 
71  
81  
 
(63, 79)  
(75, 88) 
 
55  
71 
 
(46, 63)  
(64, 79) 
 
 
 
 
Table 3. Estimates of diagnostic sensitivity (%), with associated 95% confidence intervals, (CI) 
for the IgM-ELISA and IgG-ELISA using sera from Indonesian buffaloes shown to be naturally 
infected with Trypanosoma evansi by (A) microhaematocrit technique (n = 100), (B) by mouse 
inoculation (n = 39) and (C) by either microhaematocrit technique or mouse inoculation (n = 
139). 
Test 
20% PP cut-off  30% PP cut-off  
Sensitivity  95% CI Sensitivity  95% CI 
A  
IgM-ELISA  
IgG-ELISA 
 
86  
90 
 
(78, 92)  
(82, 95) 
 
75  
85  
 
(65, 83)  
(77, 91) 
B  
IgM-ELISA  
IgG-ELISA 
 
92  
87 
 
(79, 98)  
(73, 96) 
 
87  
77 
 
(73, 96)  
(61, 89) 
C  
IgM-ELISA  
IgG-ELISA 
 
88  
89  
 
(82, 93)  
(84, 94) 
 
78  
83 
 
(72, 85)  
(77, 89) 
Predictive values 
Positive and negative predictive values for the different tests are shown in Table 4. Using a 20% 
cut-off value, the ranges of positive predictive values calculated for theoretical true prevalence 
values of 0.10 to 0.90 were 0.24 to 0.96 (2G6 Ag-ELISA) and 0.29 to 0.97 (Tbr7 Ag-ELISA). 
Positive and negative predictive values of the Tbr7 Ag-ELISA were higher compared to the 2G6 
Ag-ELISA values, and were higher at a 30% cut-off value, particularly at low true prevalence 
values. With a true prevalence of 0.50 and a 20% cut-off value, the positive predictive values of 
the 2G6 Ag-ELISA and Tbr7 Ag-ELISA were 0.74 and 0.79, respectively. The usefulness of the 
Ag-ELISAs in areas with a low trypanosomosis prevalence was questionable because the 
probability that a test-positive buffalo is truly T. evansi-infected was no greater than by chance 
alone as indicated by a positive predictive value less than 0.50. The results for the antibody 
assays showed that as true prevalence values increased, the positive predictive values of the 
IgM-ELISA and IgG-ELISA increased and the negative predictive values decreased. At a 
theoretical test prevalence of 0.50, the positive predictive values of the IgM-ELISA, IgG-ELISA 
and CATT were 0.88, 0.92 and 1.0, respectively. With all theoretical test prevalence values, the 
CATT had the highest positive predictive value (1.0) and the IgG-ELISA had highest negative 
predictive values compared with the other tests. The positive predictive value of the antigen 
assays is not sufficiently high to warrant their application in eradication programmes nor for pre-
exportation checks without other T. evansi tests. After importation of naive buffaloes, from 
Australia for example and in outbreaks of trypanosomosis, the diagnosis of T. evansi infections 
in clinical cases and the monitoring for subclinical and new infections could include MHCT tests 
in parallel with Ag-ELISAs. To increase the probability of detecting T. evansi-infected animals, 
parallel testing could be used, for example with the MHCT to detect early infections and the IgG-
ELISA to detect later infections. Serial testing using an antibody-detection ELISA and then an 
antigen-detection ELISA for all positive samples would increase the overall specificity which 
would be necessary in the final stages of an eradication campaign but there would be an 
associated decrease in overall sensitivity. 
Table 4. Positive predictive values (PPV) and negative predictive values (NPV) calculated for 
various theoretical true prevalence values (P) for (A) two Ag-ELISAs and (B) for different 
antibody detection assays. 
A 
P  
2G6 Ag-ELISA  Tbr7 Ag-ELISA 
20% PP 30% PP  20% PP  30% PP 
PPV  NPV PPV  NPV PPV NPV PPV  NPV 
0.10  0.24    0.96  0.26  0.94  0.29 0.97  0.38  0.96 
0.30  0.55 0.86 0.58  0.81  0.61 0.91  0.70  0.88 
0.50 0.74 0.72 0.76  0.65  0.79  0.80  0.85  0.75 
0.70 0.87 0.53  0.88  0.44 0.90  0.63 0.93  0.56 
0.90 0.96  0.22  0.97 0.17  0.97 0.31 0.98  0.25 
B 
P  
IgM-ELISA IgG-ELISA CATT 
PPV NPV PPV NPV PPV NPV 
0.10  0.44 0.97 0.55 0.99  1.0 0.98 
0.30 0.75 0.90 0.83 0.95 1.0 0.91 
0.50 0.88  0.80 0.92 0.89 1.0 0.82 
0.70 0.94 0.63  0.96 0.78 1.0  0.66 
0.90 0.98 0.31 0.99 0.48 1.0 0.34 
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Other diagnostic assays AB-ELISA and DNA-based test 
Antibody detection tests for diagnosis of African 
trypanosomosis 
N. Van Meirvenne 
Nationalestraat 155, B2000 Antwerp, Belgium 
African trypanosomes have a complex antigenic structure consisting of variable surface 
glycoprotein antigens (VSGs) and invariant antigens. 
The strongly immunogenic VSG defines the variable antigen type (VAT) of an individual 
trypanosome and represents about 10% of its total protein content. In the course of an infection, 
different VAT populations succeed each other in a loosely defined hierarchical order, starting 
with a series of so-called predominant VATs. Trypanosomes of the same taxon may express 
distinct VAT repertoires, with varying degrees of overlap due to cross-reacting IsoVATs. 
At the outer surface of an intact live trypanosome, only a few `external VSG epitopes' are 
exposed. These epitopes elicit VAT- or IsoVAT-specific trypanocidal antibodies with lytic, 
agglutinating and opsonising properties. After cell death or detachment of the surface coat, 
however, a large number of `internal, cryptic VSG epitopes' become exposed. Some of these 
epitopes are common to different VSGs and may be exploited in antibody detection tests. 
Trypanosomes probably contain hundreds or thousands of invariant antigens but most of them 
are minor components. As compared with VSGs, most invariant antigens are weak 
immunogens. In buffer extracts a few tens of major components can be revealed by 
immunoelectrophoresis with hyperimmune antisera (Le Ray 1975). In addition, various 
membrane-bound, non-hydrosoluble antigens have been reported, including cytoskeleton 
elements, invariant surface glycoproteins (ISGs), enzymes and receptors. Within a given 
subgenus all the trypanosome species have essentially the same major invariant antigens and 
there is also considerable overlap between subgenera. Whereas several subgenus specific 
antigens have been identified, species- and subspecies-specific antigens have not yet been 
recorded. 
The serum of an infected host thus contains a broad spectrum of antibodies to variable and 
invariant antigens. Which kind of antibodies are detectable depends on the antigen preparation 
and the test system. Tests with live bloodstream form trypanosomes, such as immune 
trypanolysis, only detect VAT-specific antibodies. Direct agglutination tests with fixed 
bloodstream forms (e.g. CATT) detect antibodies to external and internal VSG epitopes, and 
probably to some invariant surface antigens as well. Immunofluorescence tests on 
trypanosome-infected blood smear preparations detect antibodies to various VSG epitopes and 
invariant antigens. When the trypanosomes have previously been fixed in suspension with 1–
2% of formaldehyde, surface antigens become the predominant reactant. To minimise the 
interference of VSG, a mild acetone-formaldehyde fixation procedure has been proposed by 
Katende et al (1987). Tests using total buffer or detergent extracts of bloodstream from 
trypanosomes (ELISA, indirect agglutination, dot blot, Western blot, etc.) detect antibodies to 
variable and solubilised invariant antigens. In all these instances a minimal requirement to 
standardise the antigenic preparation is to start with trypanosome-clone populations of well 
defined VAT. 
Trypanosoma brucei gambiense, a causative agent of sleeping sickness, displays a limited 
diversity in VAT repertoires. Several predominant IsoVATs of this parasite have been identified 
by immune trypanolysis tests and most of the current antibody detection tests are based on the 
use of selected VATs (CATT, IFAT) or VSGs (Latex agglutination, indirect haemagglutination, 
ELISA). A similar approach seems possible for T. evansi. 
For the salivarian trypanosomes in general, further evaluation and selection of invariant 
antigens is required to develop more reliable antibody detection assays. Tests combining the 
crude antigen cocktail present in whole trypanosomes or their extracts with the cocktail of 
antibodies present in test sera have limited subgenus specificity and cross-reactions also occur 
with non-trypanosomosis samples. By increasing the serum dilution, specificity may be 
improved at the expense of sensitivity. The indirect immunofluorescence and immunoenzyme 
assays can be optimised by using anti-IgG (gamma-chain) specific conjugates. Several 
possibilities can be explored to develop more selective test systems. Direct agglutination tests 
with procyclic trypanosomes only detect antibodies to invariant surface antigens. 
Immunodiffusion tests allow the visualisation of individual immune complexes. Trypanosomes 
contain some highly specific enzymes and corresponding antibodies can be detected in host 
serum by the assay of Borowy et al 1991. Various non-hydrosoluble trypanosomal antigens, 
including cytoskeleton components, remain to be evaluated as serodiagnostic reagents. 
Since it is quite possible that the best serodiagnostic antigens are to be found among some 
minor components of the trypanosomal cell, recombinant and synthetic antigens might bring the 
final solution. 
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Nucleic acid-based systems for detection of trypanosomes 
P.A.O. Majiwa 
International Livestock Research Institute 
P.O. Box 30709, Nairobi, Kenya. 
Summary 
Diagnosis is an essential requirement in the management of disease both at the level of the 
individual, when a decision has to be made whether to treat or not, and at the epidemiological 
level for evaluating the performance of disease control strategies. An ideal diagnostic test 
should be rapid, specific, highly sensitive and amenable to automation. The test should 
distinguish closely related species of infectious organisms if the disease syndromes they cause 
require different management approaches. Furthermore, it should be of use in studies that seek 
to elucidate dynamics of the interaction of the infectious organism with its hosts, vectors and the 
environment. Recombinant DNA technology offers new approaches to the development of novel 
assays for diagnosis of African trypanosomosis, with the potential to fulfil a majority of these 
requirements. Developments made in the general area of DNA-based systems for detection of 
trypanosomes in mammalian hosts and the tsetse vector are summarised and discussed here, 
in the context of their potential contribution to epidemiology of livestock infective trypanosomes. 
Introduction 
Parasite detection and specific identification are central to the study and eventual understanding 
of the epidemiology of the diseases they cause. Accurate identification of the parasites is 
necessary for several reasons, but more particularly because of the parasite variability. African 
trypanosomes is one of the parasites with an incredible potential for variation. The best-studied 
variation in these organisms is antigenic variation involving the variant surface glycoprotein 
(VSG). In addition to antigenic variation, there are other forms of probably more subtle 
variations but which are relevant to the epidemiology of the diseases caused by the 
trypanosomes. These include mode of transmission, host and vector specificity, virulence and 
response to therapeutic drugs. Because of these variations, the identification and 
characterisation of pathogenic organisms, like the parasitic protozoa, will increasingly rely on 
the use of reagents derived from recombinant DNA (Caskey 1987; Hide and Tait 1991; Majiwa 
et al 1993). 
Recombinant DNA-based reagents are efficient, reliable and can be automated. They can be 
used to follow an infectious agent over time and space, to investigate disease incidence and 
transmission dynamics due to the infectious agents and to perform accurate diagnosis in hosts 
and vectors (Wilson 1991). 
Recombinant plasmids for detection of trypanosomes 
Over the past few years, several DNA sequences have been identified and shown to be useful 
in the specific identification of different species of the African trypanosomes infective to man and 
livestock (Majiwa et al 1985; Gibson et al 1988). These sequences identify the parasites in both 
the mammalian host blood and sera, and in the vector gut and proboscidae (Kukla et al 1987; 
Majiwa and Otieno, 1990; Masiga et al 1992). These DNA diagnostics can not only detect, but 
also distinguish the parasites at species, sub-species, antigenic repertoire and antigenic type 
levels. 
In Table 1 is a list of the recombinant plasmids containing different repetitive DNA sequences 
used as probes in the identification of different trypanosome species or types. They are all 
repetitive, being arranged either in tandem arrays or as dispersed repeats in the genome. They 
hybridise specifically with DNA from the respective trypanosome species. Their capacity to 
detect trypanosomes present in naturally infected livestock or tsetse flies has been documented 
(Majiwa and Otieno 1990; Nyeko et al 1990; McNamara and Snow 1991). When labelled to high 
specific activity, the probes can detect the parasites, in single or mixed infections, in both the 
mouth parts and guts of the tsetse vector. These probes have ordinarily been used in 
radioactive format; however, with the availability of systems for non-radioactive labelling and 
detection of DNA, they have been converted to this format (Majiwa et al 1994). 
Table 1. Recombinant plasmids containing repetitive DNA sequences specific for different 
species of the African trypanosomes. 
Parasite specificity Recombinant plasmid 
Trypanozoon pgDR1 
Trypanozoon 177repeat 
T. evansi, type A pKT420 
T. congolense (s)† pgNRE-372 
T. congolense (k) pgNIK-450 
T. congolense (t) pgNgulia-11 
T. congolense (war/f)  TSW103 
T. simiae pgNS-600 
T. vivax  lgDIL-10k 
T. vivax Tv47 
T. vivax pkDIL900 
T. vivax  pkDIL900WA 
T. vivax  pgDSIL 800/3 
†s = savannah-type T. congolense; k = Kilifi-type T. congolense; t = Tsavo-type T. congolense; war/f = 
West African forest/riverine type T. congolense. 
Sensitive detection of trypanosomes by polymerase chain reaction 
(PCR) 
The nucleotide sequence composition has been determined for a majority of the DNA probes. It 
has therefore been possible to design oligonucleotide primers (Table 2) for PCR (Saiki et al 
1988) amplification of DNA to detect low parasite numbers. Although the PCR can detect an 
extremely low number of parasites (Moser et al 1989; Solano et al 1995), the sensitivity of this 
detection can be increased by hybridisation of the PCR products with a specific probe. An 
additional advantage of this approach is that primers specific for different trypanosome species 
can be placed in a single reaction tube to perform multiplex PCR, and the products obtained 
hybridised separately with the different specific probes. These reagents have made it possible 
to perform investigations which were impossible to do in the past, leading to a more accurate 
description of species prevalence (McNamara and Snow 1991; Nyeko et al 1990), the discovery 
of new trypanosome genotypes (Majiwa et al 1993; McNamara et al 1994) and the 
demonstration of the presence of trypanosomes in cattle in which such parasites could not be 
detected by microscopy or xenodiagnosis (Majiwa et al 1994). 
Future prospects 
Further refinements and improvements of these DNA-based diagnostics will have to include 
conversion of the assays to ELISA format (Nutman et al 1994), and the quantification of the 
parasites in infected hosts/vectors by quantitative PCR. 
These refinements will lead to their wider application, for better understanding of the relative 
contribution of different trypanosome species to the epidemiology of trypanosomosis, monitoring 
control programmes, i.e. tsetse control or livestock treatment campaigns, and conservation of 
wildlife biodiversity (Mihok et al 1992). 
It is envisaged that with the advent of genome analyses efforts, DNA markers will be found that 
are linked to specific parasite phenotypes, like drug resistance and virulence. Nucleic acid 
diagnostics based upon such markers will be most useful in investigating the prevalence and 
direct consequences of these phenotypes. 
As more information is gained regarding ways in which different parasites cause pathology in 
their respective hosts, it will be possible to device nucleic acid-based diagnostics which can 
provide an index of pathology or host morbidity resulting directly from the infection by a 
particular parasite type. 
Because of future prospects of DNA diagnostics, many commercial companies have invested in 
the emerging field of genomics, with a hope of exploiting the information coming from the 
different genome analyses projects, to develop novel diagnostic kits for detection of genetic 
mutations and infectious organisms. Although there are no kits produced so far for the detection 
of parasitic protozoa, they will be relatively easy to develop once appropriate markers have 
been identified. The primary task remains that of identifying DNA markers, genes or gene 
mutations linked to specific phenotypes. Once such markers are in hand, they can be 
incorporated in novel diagnostic assays such as: (a) oligonucleotide ligation assay (OLA; Tobe 
et al 1996), employed in the detection and typing of polymorphisms arising from small deletions 
or insertions, often found in diallelic variants; (b) nucleic acid sequence-based amplification 
(NASBATM; van der Vliet et al 1993) which involves alternate steps in synthesis of DNA from 
RNA template and synthesis of RNA from the DNA template in a homogenous isothermal 
amplification process; and (c) systematic evolution of ligands by exponential enrichment 
(SELEX; Tuerk 1997), an assay system that exploits combinatorial chemistry to identify an 
oligonucleotide with a high specificity to a particular molecule. Once an oligonucleotide with the 
desired binding specificity has been identified, it is used in the enzyme-linked oligonucleotide 
assay (ELONA; Drolet et al 1996) to quantify levels of the analyte molecule in the test sera. 
SELEX-derived ligands are precise, accurate and specific. 
Table 2. Oligonucleotide primers for specific amplification of DNA from different trypanosomes. 
Primer 
number or 
designation Sequence of the primer 
PCR 
product 
size 
(bp) 
Trypanosome 
specificity Reference 
ILO342 
IL0343 
GAT CCG CAG CCG GGC CTG  
CCG CGG TGG CTC CTT CCC 
1500 Trypanozoon 
Majiwa et 
al 1994 
ILO344 
ILO345 
CGA GCG AGA ACG GGC AC 
GGG ACA AAC AAA TCC CGC 
370  T. congolense(s†) 
Majiwa et 
al 1994 
ILO892 
ILO893 
CGA GCA TGC AGG ATG GCC G 
GTC CTG CCA CCG AGT ATG C 
400 T. congolense(t) 
Majiwa et 
al 1994 
ILO963 
ILO968 
GCT GCA GGT CGA CGG ATC 
CCC TCG AGA ACG AGC A 
450 T. congolense(k) 
Majiwa et 
al 1994 
TCF1 
TCF2 
GGA CAC GCC AGA AGG TAC TT 
GTT CTC GCA CCA AAT CCA AC 
350 
T. 
congolense(war/f) 
Masiga et 
al 1992 
TSM1  
TSM2 
CCG GTC AAA AAC GCA TT 
AGT CGC CCG GAG TCG AT 
437   T. simiae 
Masiga et 
al 1992 
TVW1 
TVW2 
CTG AGT GCT CCA TGT GCC AC 
CCA CCA GAA CAC CAA CCT GA  
150 T. vivax 
Masiga et 
al 1992 
ILO1264 
ILO1265 
CAG CTC GCC GAA GGC CAC TTG GCT GGG 
CG CTA CCA CAG TCG CAA TCG TCG TCT CAA GG 
400 T. vivax 
Masake et 
al 1997 
†s = Savannah-type T. congolense; k = Kilifi-type T. congolense; t = Tsavo-type T. congolense; war/f = 
West African riverine/forest type T. congolense. 
Conclusion 
In general, DNA-based diagnostic reagents require no animals and are therefore not subject to 
animal variation during synthesis; they or detailed information about them are most often 
available in the public domain databases and from this they can be consistently re-synthesised 
or re-cloned anywhere in the world. Additionally, the target molecule upon which they are based 
need not be immunogenic since the detection system will most often be based on invariant 
segments of the genome. The reagents are normally stable during storage and the assays can 
be automated. 
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Summary and conclusions 
Summary of discussion groups 
Participants were divided into four discussion groups, covering two discussion topics. One 
group discussed the shortcomings of the Ag-ELISA test and possible solutions. The other three 
groups discussed the more general priorities and technical requirements for trypanosomosis 
diagnosis. Their discussions are summarised below. 
Topic I. Ag-ELISA: current problems and potential solutions 
Problems 
 Both diagnostic sensitivity and specificity are lower than desired and highly variable. 
 The three species-specific tests often do not give species-specific results. 
 The reasons for this variable performance are unknown; thus, the assays cannot be 
sufficiently improved by simple modifications. The actual working principle underlying the 
assay remains obscure. 
Potential solutions 
Identify which substances are detected or interfere with the assay 
 The actual substances detected by the assay need to be determined. These could be 
target antigens either unbound or bound in the form of immune complexes. 
 A number of substances may interfere with the assay causing either false positives or 
false negatives. Some potential interfering substances include:  
 anti-Ig antibodies 
 heterophile antibodies 
 anti-idiotype anitbodies 
 complement components. 
 Once interfering substances are identified, specific measures (e.g. heat inactivation, 
additives, etc.) could be taken to counteract their effects and thus improve the sensitivity 
and specificity of the assay. 
Better positive and negative controls in the test kit 
 Positive controls: freeze-dried trypanosome extract or purified antigen should be 
included. 
 Negative controls: a dummy mouse IgG would be of benefit. 
Revise the level of discrimination to which trypanosomes are identified 
 The target level of specificity of test kits for differentiating trypanosomes could be revised 
from the species to the subgenus level as follows:  
 Tryapanozoon (T. brucei, T. evansi, T. equiperdum) 
 Nannomonas (T. congolense) 
 Dutonella (T. vivax) 
 In addition, a salivarian kit might be envisaged. 
Improve selection of candidate target antigens and antibodies 
 The theoretically optimal target antigens should have the following characteristics: 
1. subgenus or salivarian specific 
2. present in high concentrations in trypanosomes 
3. weakly immunogenic (to minimise elimination or interference by immune 
complexes) 
 The capturing antibodies should be of the IgG isotype. Either a combination of 
monoclonal antibodies or even the IgG fraction of a polyclonal antiserum should be used 
in preference to a single monoclonal. 
 A number of immunisation procedures should be considered for generating appropriate 
capturing antibodies. Possible immunogens include purified native antigens, 
recombinant or denatured antigens and infected host serum. 
 The revealing monoclonal antibodies should also be of the IgG isotype but they should 
recognise different epitopes than the capturing antibodies. 
Catalogue existing analytes 
 An inventory of existing monoclonal antibodies and well-studied antigens should be 
assembled along with their bibliographic references. 
Topic II. Trypanosomosis diagnosis: priorities and technical 
requirements 
General diagnostic needs 
All groups defined the needs for further test development in terms of different target domains. 
Two target domains were defined, the farm or animal level and the area level. Areas were 
defined to be either agro-ecological zones or other regional or national subdivision. 
Consideration of trypanosome target species was also thought to be potentially important. The 
diagnostic needs for trypanosome detection in the field for each of the two target domains were 
considered as follows. 
Animal/farm level 
 Diagnosis of presence or absence of infection is essential. 
 Differentiation between parasite species is less important. 
 A crush side test is necessary for timely diagnosis and treatment. 
 Analytic sensitivity is more important for chronic than acute infections. 
 It is important to be able to assess the efficacy of treatment, particularly for group 
treatments (tsetse control or block chemo-prophylaxis). 
Area level 
 The basic need is to estimate the prevalence in livestock rather than the incidence of 
new infections. 
 The determination of tsetse density and vector infection rate is also important in order to 
match tsetse challenge to trypanosome infection rates in hosts. 
 The differentiation of trypanosomes by species or sub-genus will be required for 
epidemiological research into infection transmission dynamics but not for general 
surveillance, for which broad spectrum diagnostic tests would be adequate. 
Potential applications for different diagnostic tests 
 For the determination of prevalence or incidence of current infections at both farm or 
area level, all diagnostic tests except the Ab-ELISA test were considered appropriate. 
 For differention to species level, DNA methods are likely to be the most appropriate. 
 The Ab-ELISA test, however, could be a satisfactory alternative for assessing the spatial 
distribution of prevalence of trypanasomosis at the area level. 
 The Ab-ELISA might also be a suitable alternative to the Ag-ELISA in longitudinal 
monitoring of the impact of a trypanasomosis control programme, particularly for 
comparing the prevalence of trypanosomes in animals born following the intervention 
between treatment and control areas. 
Current and desired sensitivity and specificity requirements 
Using ratings from 1 (low) to 5 (high) for sensitivity and specificity, one group produced the 
following table. 
Table 1. Summary of current and desired specificities and sensitivities for different 
trypanosomosis diagnostic tests. 
 
Analytical  
specificity 
Analytical  
sensitivity 
Diagnostic 
specificity 
Diagnostic  
sensitivity  
Current desired Current desired Current desired Current desired 
Ab-ELISA 1 3 3 3 – – – – 
Ag-ELISA 2 4 1 5 3 5 1 5 
DNA 5 5 5 5 ? 5 ? 5 
Buffy coat  4 4 1 2 5 5 1 2 
On current test performance the following points were made: 
 The only definitive test at present is the buffy coat test. 
 The currently available versions of the Ag-ELISA test fall short of the overall desired 
requirements for both specificity and sensitivity. It does not discriminate well between 
positive and negative populations. 
 The lack of correlation between parasitaemia and antigenaemia in various studies is also 
a concern with respect to the performance of the Ag-ELISA test. 
 The relative robustness of the different tests were discussed. It was considered that 
major improvements in quality assurance in terms of consistency of sensitivity, specificity 
and robustness, both within and between laboratories, were essential for each of the Ab-
ELISA, Ag-ELISA and DNA tests. 
 It was felt that a higher diagnostic sensitivity could be achieved with any of the Ab-
ELISA, Ag-ELISA or DNA tests than was possible by the buffy coat test. However, the 
current low levels of diagnostic sensitivity in Table 2 demonstrate that major efforts are 
needed to improve test performance. 
 Future test development must include careful validation in both the laboratory and the 
field. 
Conclusions 
General 
A panel of invited participants (T. de Waal, J. McDermott, P. Wright and P. van Meirvenne) met 
and summarised the contributions of the discussion groups with respect to the main diagnostic 
requirements and potential applications of diagnostic tests for trypanosomosis. The main 
summary points were: 
1. Participants felt that there were applications for all the detection systems that are either 
available now or under development. These include antigen, antibody, nucleic acid and 
parasite detection systems. 
2. The only definitive tests at present are the parasite detection methods. 
3. Parasite detection methods define the minimum diagnostic standard for sensitivity, which 
new tests must achieve. 
4. Broad spectrum tests for pathogenic trypanosomes (salivarian tryps; 3 sub-genera) 
would be sufficient for routine use in the field. 
5. The antibody and antigen-detection tests have potential broad-spectrum application. 
6. There is a need for subgenera-specific tests. Tests based on the detection of nucleic 
acids have the best potential for this purpose. 
These summary points were then presented to all participants and a general discussion on the 
diagnostic testing needs and options took place. These are summarised below. 
Diagnostic needs 
Diagnostic needs were identified by discussion groups for various situations. These were further 
discussed and five major situations were identified. 
1. Spatial distribution of trypanosomosis: consistent test required; lack of sensitivity could 
be overcome by increased sample size. 
2. Impact of control programmes: consistent test required; greater sensitivity required, 
particularly if short-term impact to be assessed; improved tests could be useful. 
3. Declaration of eradication: higher sensitivity and specificity required; currently available 
tests were inadequate. 
4. Diagnosis for herd-level chemoprophylaxis: decision will be based on a herd prevalence 
threshold; parasite detection probably adequate for this. 
5. Diagnosis for animal-level chemotherapy: current infection needs to be detected; better 
combination of sensitivity and specificity required. 
These general needs were then summarised in tabular form (Table 2) into three domains and 
the potential test systems for each domain agreed upon. 
Table 2. Summary of main diagnostic needs for trypanosomosis in the field. 
Application Level Location Analyte Broad Specific Technology 
Survey 
(prevalence, 
monitoring) 
Regional, 
National 
Subnational 
Laboratory 
Farm 
Ab 
Pa 
Na 
x  
x 
x 
Ab-ELISA 
Buffy coat or 
slide 
Surveillance National 
Subnational 
Farm 
Laboratory 
Farm 
Pa 
Ag 
Ab 
Na 
 
x 
x 
x 
 
 
x 
Buffy coat  
Ag-ELISA 
Ab-ELISA 
Nucleic acid 
test 
Diagnosis Farm Farm 
Laboratory 
Pa 
Na 
Ag 
x 
 
x 
x 
x 
Buffy coat 
Nucleic acid 
test Ag-
ELISA 
Ab = antibody; Na = nucleic acid; Pa = parasite; Ag = antigen 
Field experience with available diagnostic tests 
1. The Regional Tsetse and Trypanosomosis Control Programme (RTTCP) in southern 
Africa was satisfied with the performance of the buffy coat and Ab-ELISA test for 
surveys. They use buffy coat for surveillance but would prefer a more sensitive test if 
available. They felt a pen-side test for individual animal chemotherapy decisions was 
required. 
2. For trypanotolerance selection in the field, Dr Guy d'Ieteren considered that the antigen 
test provided further information beyond parasite detection for the identification of 
trypanotolerant animals. He thought that the Ag-ELISA test performed well for studies of 
trypanotolerance. 
State of development of antigen, antibody and nucleic acid diagnostic tests 
The status of resources and reagents available for each main diagnostic test category was 
discussed and a tabular summary (Table 3) agreed upon. 
Table 3. Test systems being developed for trypanosomosis: current availability of main test 
development requirements. 
Developmental 
requirements 
Antigen-detection Antibody-detection   Nucleic acid tests 
Now 
To 
develop 
Now To develop Now 
To 
develop 
Available expertise 
      
Standard analytes 
     
+/– 
Quality assurance +/– 
 
+/– 
   
Reagents +/– 
    
+/– 
Protocols +/– 
 
+/– 
   
Recommendations 
Recommendations for immediate action in diagnostic test 
development for trypanosomosis 
1. Emphasis should be given to the development of a broad-spectrum test(s), either 
antigen or antibody detection, which has consistent performance across different regions 
and disease states. 
2. Species identification will be important for more detailed epidemiological studies. 
Identification to the sub-genus level would be sufficient for most applications. Nucleic 
acid tests were agreed to be the most promising route for the differentiation of sub-
genera and species. 
3. Criteria need to be developed for the standardised comparison of the analytical 
performance of all tests at the same time. This needs to be done with samples from 
different sites and different disease states. 
4. In the immediate future, the standardised comparison should focus on broad-spectrum 
tests for pathogenic trypanosomes. All tests (e.g. antibody, antigen) developed for this 
purpose should be evaluated for analytical performance together. 
5. Critical evaluation of the feasibility of larger scale development of a broad-spectrum test 
should only be performed when the evaluation of analytical performance has been 
made. 
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